Int64Index: 251 entries, 53 to 12865 memory usage: 15.7+ KB
count null dtype
column
WkD_disease 251 non-null object
WkD_diseaseLabel 251 non-null object
WP_en_article 251 non-null object
class 251 non-null object
importance 251 non-null object
taskForces 251 non-null object
cochrane_reviews_html 251 non-null object

Table Guide:

Grouping:

In cases, where there are multiple version of a Cochrane review, they are grouped toghther (showing the same background color) ,and are listed chronologically,latest version first.

Color Codes:

  1. Green: up-to-date and CITED

  2. Red: up-to-date and NOT CITED

  3. Orange: out-of-date and CITED

  4. Grey: out-of-date and NOT CITED

Results Table contains 251 rows

WkD_disease WkD_diseaseLabel WP_en_article class importance taskForces cochrane_reviews_html
index
4357 Q12078 cancer Cancer B 1-Top

Hematology-oncology

Pathology
  1. Abdominal drainage versus no drainage post-gastrectomy for gastric cancer. PMID: 25961741 [NOT CITED] [LATEST Version]
  2. Acupuncture for cancer pain in adults. PMID: 26468973 [NOT CITED] [LATEST Version]
  3. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 26676202 [NOT CITED] [LATEST Version]
  4. Adjuvant platinum-based chemotherapy for early stage cervical cancer. PMID: 27873308 [NOT CITED] [LATEST Version]
  5. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. PMID: 29084357 [NOT CITED] [LATEST Version]
  6. Anticoagulation for people with cancer and central venous catheters. PMID: 29856471 [NOT CITED] [LATEST Version]
  7. Anticoagulation for perioperative thromboprophylaxis in people with cancer. PMID: 29993117 [NOT CITED] [LATEST Version]
  8. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer. PMID: 29363105 [NOT CITED] [LATEST Version]
  9. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. PMID: 29920657 [NOT CITED] [LATEST Version]
  10. Antidepressants for chronic non-cancer pain in children and adolescents. PMID: 28779487 [NOT CITED] [LATEST Version]
  11. Antidepressants for the treatment of depression in people with cancer. PMID: 29683474 [NOT CITED] [LATEST Version]
  12. Antidepressants for the treatment of depression in people with cancer. PMID: 26029972 [NOT CITED] [OLD Version]
  13. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. PMID: 28779491 [NOT CITED] [LATEST Version]
  14. Antigen-specific active immunotherapy for ovarian cancer. PMID: 30199097 [NOT CITED] [LATEST Version]
  15. Axillary treatment for operable primary breast cancer. PMID: 28052186 [NOT CITED] [LATEST Version]
  16. Bisphosphonates and other bone agents for breast cancer. PMID: 29082518 [NOT CITED] [LATEST Version]
  17. Bisphosphonates for advanced prostate cancer. PMID: 29278410 [NOT CITED] [LATEST Version]
  18. Blood CEA levels for detecting recurrent colorectal cancer. PMID: 26661580 [NOT CITED] [LATEST Version]
  19. Breast surgery for metastatic breast cancer. PMID: 29542106 [NOT CITED] [LATEST Version]
  20. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. PMID: 26561338 [NOT CITED] [LATEST Version]
  21. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. PMID: 28829911 [NOT CITED] [LATEST Version]
  22. Chemotherapy and radiotherapy for advanced pancreatic cancer. PMID: 29557103 [NOT CITED] [LATEST Version]
  23. Chemotherapy for advanced gastric cancer. PMID: 28850174 [NOT CITED] [LATEST Version]
  24. Chemotherapy for advanced non-small cell lung cancer in the elderly population. PMID: 26482542 [NOT CITED] [LATEST Version]
  25. Chinese herbal medicine for oesophageal cancer. PMID: 26799001 [NOT CITED] [LATEST Version]
  26. Communication skills training for healthcare professionals working with people who have cancer. PMID: 30039853 [NOT CITED] [LATEST Version]
  27. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. PMID: 30521691 [NOT CITED] [LATEST Version]
  28. Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). PMID: 28671265 [NOT CITED] [LATEST Version]
  29. Corticosteroids for the management of cancer-related pain in adults. PMID: 25908299 [NOT CITED] [LATEST Version]
  30. Cytology versus HPV testing for cervical cancer screening in the general population. PMID: 28796882 [NOT CITED] [LATEST Version]
  31. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. PMID: 27631326 [NOT CITED] [LATEST Version]
  32. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. PMID: 27383694 [NOT CITED] [LATEST Version]
  33. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. PMID: 26021841 [NOT CITED] [LATEST Version]
  34. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy. PMID: 26938118 [NOT CITED] [LATEST Version]
  35. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. PMID: 29975402 [NOT CITED] [LATEST Version]
  36. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. PMID: 27498707 [NOT CITED] [OLD Version]
  37. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. PMID: 30855726 [NOT CITED] [LATEST Version]
  38. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer. PMID: 30605229 [NOT CITED] [LATEST Version]
  39. Early palliative care for adults with advanced cancer. PMID: 28603881 [NOT CITED] [LATEST Version]
  40. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer. PMID: 31194882 [NOT CITED] [LATEST Version]
  41. Educational interventions for the management of cancer-related fatigue in adults. PMID: 27883365 [NOT CITED] [LATEST Version]
  42. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE. PMID: 25749503 [NOT CITED] [LATEST Version]
  43. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 28832905 [NOT CITED] [LATEST Version]
  44. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 30407621 [NOT CITED] [LATEST Version]
  45. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. PMID: 26801659 [NOT CITED] [LATEST Version]
  46. Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. PMID: 28577308 [NOT CITED] [LATEST Version]
  47. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. PMID: 28654140 [NOT CITED] [LATEST Version]
  48. Epidermal growth factor receptor blockers for the treatment of ovarian cancer. PMID: 30321910 [NOT CITED] [LATEST Version]
  49. Exercise for reducing falls in people living with and beyond cancer. PMID: 30320433 [NOT CITED] [LATEST Version]
  50. Exercise for women receiving adjuvant therapy for breast cancer. PMID: 27650122 [NOT CITED] [LATEST Version]
  51. Exercise interventions for people undergoing multimodal cancer treatment that includes surgery. PMID: 30536366 [NOT CITED] [LATEST Version]
  52. Exercise training for advanced lung cancer. PMID: 30741408 [NOT CITED] [LATEST Version]
  53. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. PMID: 31204439 [NOT CITED] [LATEST Version]
  54. Extended-field radiotherapy for locally advanced cervical cancer. PMID: 30362204 [NOT CITED] [LATEST Version]
  55. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. PMID: 27223332 [NOT CITED] [LATEST Version]
  56. Follow-up strategies for patients treated for non-metastatic colorectal cancer. PMID: 31483854 [NOT CITED] [LATEST Version]
  57. Follow-up strategies for patients treated for non-metastatic colorectal cancer. PMID: 27884041 [NOT CITED] [OLD Version]
  58. Follow-up strategies for women treated for early breast cancer. PMID: 27230946 [NOT CITED] [LATEST Version]
  59. Fraction size in radiation therapy for breast conservation in early breast cancer. PMID: 27425588 [NOT CITED] [LATEST Version]
  60. Fulvestrant for hormone-sensitive metastatic breast cancer. PMID: 28043088 [NOT CITED] [LATEST Version]
  61. Ganoderma lucidum (Reishi mushroom) for cancer treatment. PMID: 27045603 [NOT CITED] [LATEST Version]
  62. Gefitinib for advanced non-small cell lung cancer. PMID: 29336009 [NOT CITED] [LATEST Version]
  63. Ghrelin for the management of cachexia associated with cancer. PMID: 29489032 [NOT CITED] [LATEST Version]
  64. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. PMID: 30985922 [NOT CITED] [LATEST Version]
  65. High dose, high risk? What updated evidence tells us about chemotherapy dosing in early breast cancer. PMID: 27241086 [NOT CITED] [LATEST Version]
  66. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. PMID: 27200512 [NOT CITED] [LATEST Version]
  67. High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews. PMID: 29084358 [NOT CITED] [LATEST Version]
  68. High-frequency ultrasound for diagnosing skin cancer in adults. PMID: 30521683 [NOT CITED] [LATEST Version]
  69. Home-based multidimensional survivorship programmes for breast cancer survivors. PMID: 28836379 [NOT CITED] [LATEST Version]
  70. Hormone replacement therapy for women previously treated for endometrial cancer. PMID: 29763969 [NOT CITED] [LATEST Version]
  71. Hydromorphone for cancer pain. PMID: 27727452 [NOT CITED] [LATEST Version]
  72. Hypofractionation for clinically localized prostate cancer. PMID: 31476800 [NOT CITED] [LATEST Version]
  73. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. PMID: 25847525 [NOT CITED] [LATEST Version]
  74. Immunonutrition for patients undergoing surgery for head and neck cancer. PMID: 30160300 [NOT CITED] [LATEST Version]
  75. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. PMID: 29247502 [NOT CITED] [LATEST Version]
  76. Influenza vaccines in immunosuppressed adults with cancer. PMID: 29388675 [NOT CITED] [LATEST Version]
  77. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 26747297 [NOT CITED] [LATEST Version]
  78. Interventions for cough in cancer. PMID: 25989380 [NOT CITED] [LATEST Version]
  79. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. PMID: 29181845 [NOT CITED] [LATEST Version]
  80. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. PMID: 26695736 [NOT CITED] [LATEST Version]
  81. Interventions for promoting habitual exercise in people living with and beyond cancer. PMID: 30229557 [NOT CITED] [LATEST Version]
  82. Interventions for promoting participation in shared decision-making for children with cancer. PMID: 27898175 [NOT CITED] [LATEST Version]
  83. Interventions for raising breast cancer awareness in women. PMID: 28185268 [NOT CITED] [LATEST Version]
  84. Interventions for sexual dysfunction following treatments for cancer in women. PMID: 26830050 [NOT CITED] [LATEST Version]
  85. Interventions for smoking cessation in people diagnosed with lung cancer. PMID: 31173336 [NOT CITED] [LATEST Version]
  86. Interventions for smoking cessation in people diagnosed with lung cancer. PMID: 26632766 [NOT CITED] [OLD Version]
  87. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. PMID: 29130474 [NOT CITED] [LATEST Version]
  88. Interventions for treating oral leukoplakia to prevent oral cancer. PMID: 27471845 [NOT CITED] [LATEST Version]
  89. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. PMID: 29388687 [NOT CITED] [LATEST Version]
  90. Interventions to encourage uptake of cancer screening for people with severe mental illness. PMID: 27668891 [NOT CITED] [LATEST Version]
  91. Interventions to enhance return-to-work for cancer patients. PMID: 26405010 [NOT CITED] [LATEST Version]
  92. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. PMID: 26930463 [NOT CITED] [LATEST Version]
  93. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. PMID: 26755441 [NOT CITED] [LATEST Version]
  94. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer. PMID: 28268259 [NOT CITED] [LATEST Version]
  95. Intravesical electromotive drug administration for non-muscle invasive bladder cancer. PMID: 28898400 [NOT CITED] [LATEST Version]
  96. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer. PMID: 26869023 [NOT CITED] [LATEST Version]
  97. Ketamine as an adjuvant to opioids for cancer pain. PMID: 28657160 [NOT CITED] [LATEST Version]
  98. Laetrile treatment for cancer. PMID: 25918920 [NOT CITED] [LATEST Version]
  99. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. PMID: 28895658 [NOT CITED] [LATEST Version]
  100. Laparoscopic versus open distal pancreatectomy for pancreatic cancer. PMID: 27043078 [NOT CITED] [LATEST Version]
  101. Laparoscopic versus open gastrectomy for gastric cancer. PMID: 27030300 [NOT CITED] [LATEST Version]
  102. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer. PMID: 27030301 [NOT CITED] [LATEST Version]
  103. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. PMID: 30907434 [NOT CITED] [LATEST Version]
  104. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. PMID: 27737492 [NOT CITED] [LATEST Version]
  105. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. PMID: 30379327 [NOT CITED] [LATEST Version]
  106. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. PMID: 26649916 [NOT CITED] [LATEST Version]
  107. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. PMID: 27107610 [NOT CITED] [LATEST Version]
  108. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer. PMID: 27356090 [NOT CITED] [LATEST Version]
  109. Lymphadenectomy for the management of endometrial cancer. PMID: 28968482 [NOT CITED] [LATEST Version]
  110. Lymphadenectomy for the management of endometrial cancer. PMID: 26387863 [NOT CITED] [OLD Version]
  111. Manual lymphatic drainage for lymphedema following breast cancer treatment. PMID: 25994425 [NOT CITED] [LATEST Version]
  112. Massage with or without aromatherapy for symptom relief in people with cancer. PMID: 27258432 [NOT CITED] [LATEST Version]
  113. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. PMID: 31063591 [NOT CITED] [LATEST Version]
  114. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. PMID: 27669661 [NOT CITED] [OLD Version]
  115. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. PMID: 27552363 [NOT CITED] [LATEST Version]
  116. Methadone for cancer pain. PMID: 28177515 [NOT CITED] [LATEST Version]
  117. Mindfulness-based stress reduction for women diagnosed with breast cancer. PMID: 30916356 [NOT CITED] [LATEST Version]
  118. Molecular-targeted first-line therapy for advanced gastric cancer. PMID: 27432490 [NOT CITED] [LATEST Version]
  119. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. PMID: 30480754 [NOT CITED] [LATEST Version]
  120. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. PMID: 29869799 [NOT CITED] [LATEST Version]
  121. Music interventions for improving psychological and physical outcomes in cancer patients. PMID: 27524661 [NOT CITED] [LATEST Version]
  122. Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa). PMID: 30746689 [NOT CITED] [LATEST Version]
  123. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. PMID: 27898991 [NOT CITED] [LATEST Version]
  124. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. PMID: 30840317 [NOT CITED] [LATEST Version]
  125. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. PMID: 26407182 [NOT CITED] [OLD Version]
  126. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. PMID: 27529826 [NOT CITED] [LATEST Version]
  127. Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents. PMID: 28737843 [NOT CITED] [LATEST Version]
  128. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. PMID: 28770976 [NOT CITED] [LATEST Version]
  129. Non-surgical versus surgical treatment for oesophageal cancer. PMID: 27021481 [NOT CITED] [LATEST Version]
  130. Nutritional interventions for survivors of childhood cancer. PMID: 27545902 [NOT CITED] [LATEST Version]
  131. Nutritional support in children and young people with cancer undergoing chemotherapy. PMID: 26301790 [NOT CITED] [LATEST Version]
  132. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. PMID: 30246876 [NOT CITED] [LATEST Version]
  133. Online support groups for women with breast cancer. PMID: 28278559 [NOT CITED] [LATEST Version]
  134. Opioids for cancer pain - an overview of Cochrane reviews. PMID: 28683172 [NOT CITED] [LATEST Version]
  135. Opioids for cancer-related pain in children and adolescents. PMID: 28722116 [NOT CITED] [LATEST Version]
  136. Opioids for chronic non-cancer pain in children and adolescents. PMID: 28745394 [NOT CITED] [LATEST Version]
  137. Optical coherence tomography for diagnosing skin cancer in adults. PMID: 30521690 [NOT CITED] [LATEST Version]
  138. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. PMID: 29285754 [NOT CITED] [LATEST Version]
  139. Oral morphine for cancer pain. PMID: 27105021 [NOT CITED] [LATEST Version]
  140. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. PMID: 28700091 [NOT CITED] [LATEST Version]
  141. Oral paracetamol (acetaminophen) for cancer pain. PMID: 28700092 [NOT CITED] [LATEST Version]
  142. Oral tapentadol for cancer pain. PMID: 26403220 [NOT CITED] [LATEST Version]
  143. Oral versus intravenous fluoropyrimidines for colorectal cancer. PMID: 28752564 [NOT CITED] [LATEST Version]
  144. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. PMID: 30887505 [NOT CITED] [LATEST Version]
  145. Oxycodone for cancer-related pain. PMID: 28829910 [NOT CITED] [LATEST Version]
  146. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. PMID: 29182797 [NOT CITED] [LATEST Version]
  147. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 30888060 [NOT CITED] [LATEST Version]
  148. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 25932968 [NOT CITED] [OLD Version]
  149. Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents. PMID: 28770975 [NOT CITED] [LATEST Version]
  150. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 28892556 [CITED] [LATEST Version]
  151. Partial breast irradiation for early breast cancer. PMID: 27425375 [NOT CITED] [LATEST Version]
  152. Perioperative nutrition for the treatment of bladder cancer by radical cystectomy. PMID: 31107970 [NOT CITED] [LATEST Version]
  153. Physical activity for women with breast cancer after adjuvant therapy. PMID: 29376559 [NOT CITED] [LATEST Version]
  154. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. PMID: 27030386 [NOT CITED] [LATEST Version]
  155. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 26233609 [NOT CITED] [LATEST Version]
  156. Platinum-containing regimens for metastatic breast cancer. PMID: 28643430 [NOT CITED] [LATEST Version]
  157. Platinum-induced hearing loss after treatment for childhood cancer. PMID: 27486906 [NOT CITED] [LATEST Version]
  158. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. PMID: 25991068 [NOT CITED] [LATEST Version]
  159. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. PMID: 30298516 [NOT CITED] [LATEST Version]
  160. Postoperative radiotherapy for non-small cell lung cancer. PMID: 27727451 [NOT CITED] [LATEST Version]
  161. Postoperative radiotherapy for non-small cell lung cancer. PMID: 27684386 [NOT CITED] [OLD Version]
  162. Preoperative chemotherapy for resectable thoracic esophageal cancer. PMID: 25988291 [NOT CITED] [LATEST Version]
  163. Preoperative exercise training for patients with non-small cell lung cancer. PMID: 28589547 [NOT CITED] [LATEST Version]
  164. Primary cryotherapy for localised or locally advanced prostate cancer. PMID: 29845595 [NOT CITED] [LATEST Version]
  165. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. PMID: 27906452 [NOT CITED] [LATEST Version]
  166. Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer. PMID: 30168576 [NOT CITED] [LATEST Version]
  167. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. PMID: 26687844 [NOT CITED] [LATEST Version]
  168. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. PMID: 31557310 [NOT CITED] [LATEST Version]
  169. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. PMID: 29740819 [NOT CITED] [LATEST Version]
  170. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. PMID: 31022301 [NOT CITED] [LATEST Version]
  171. Psychological interventions for women with non-metastatic breast cancer. PMID: 26017383 [NOT CITED] [LATEST Version]
  172. Psychosocial interventions for fatigue during cancer treatment with palliative intent. PMID: 28708236 [NOT CITED] [LATEST Version]
  173. Psychosocial interventions for informal caregivers of people living with cancer. PMID: 31204791 [NOT CITED] [LATEST Version]
  174. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. PMID: 28349511 [NOT CITED] [LATEST Version]
  175. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. PMID: 31207666 [NOT CITED] [LATEST Version]
  176. Risk-reducing mastectomy for the prevention of primary breast cancer. PMID: 29620792 [NOT CITED] [LATEST Version]
  177. Risk-reducing medications for primary breast cancer: a network meta-analysis. PMID: 31032883 [NOT CITED] [LATEST Version]
  178. Robotic versus open radical cystectomy for bladder cancer in adults. PMID: 31016718 [NOT CITED] [LATEST Version]
  179. Screening for nasopharyngeal cancer. PMID: 26544798 [NOT CITED] [LATEST Version]
  180. Second-line systemic therapy for metastatic colorectal cancer. PMID: 28128439 [NOT CITED] [LATEST Version]
  181. Selenium for preventing cancer. PMID: 29376219 [CITED] [LATEST Version]
  182. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. PMID: 30776132 [NOT CITED] [LATEST Version]
  183. Spinal cord stimulation for cancer-related pain in adults. PMID: 26121600 [NOT CITED] [LATEST Version]
  184. Strategies for detecting colon cancer in patients with inflammatory bowel disease. PMID: 28922695 [NOT CITED] [LATEST Version]
  185. Surgery for limited-stage small-cell lung cancer. PMID: 28429473 [NOT CITED] [LATEST Version]
  186. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. PMID: 26727399 [NOT CITED] [LATEST Version]
  187. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. PMID: 30779124 [NOT CITED] [LATEST Version]
  188. Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer. PMID: 30480771 [NOT CITED] [LATEST Version]
  189. Systematic screening and assessment of psychosocial well-being and care needs of people with cancer. PMID: 30909317 [NOT CITED] [LATEST Version]
  190. Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults. PMID: 30784058 [NOT CITED] [LATEST Version]
  191. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer. PMID: 30320443 [NOT CITED] [LATEST Version]
  192. Taxane-containing regimens for metastatic breast cancer. PMID: 26058962 [NOT CITED] [LATEST Version]
  193. Taxanes for adjuvant treatment of early breast cancer. PMID: 31476253 [NOT CITED] [LATEST Version]
  194. Teledermatology for diagnosing skin cancer in adults. PMID: 30521686 [NOT CITED] [LATEST Version]
  195. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. PMID: 26845108 [NOT CITED] [LATEST Version]
  196. Tramadol with or without paracetamol (acetaminophen) for cancer pain. PMID: 28510996 [NOT CITED] [LATEST Version]
  197. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer. PMID: 30311942 [NOT CITED] [LATEST Version]
  198. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. PMID: 28272834 [NOT CITED] [LATEST Version]
  199. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia. PMID: 26899263 [NOT CITED] [LATEST Version]
  200. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. PMID: 28045199 [NOT CITED] [LATEST Version]
262 Q181257 prostate cancer Prostate cancer B 1-Top

Hematology-oncology
  1. Adjuvant radiotherapy following radical prostatectomy for prostate cancer. PMID: 22161411 [NOT CITED] [LATEST Version]
  2. Anaesthetic techniques for risk of malignant tumour recurrence. PMID: 25379840 [NOT CITED] [LATEST Version]
  3. Bisphosphonates for advanced prostate cancer. PMID: 29278410 [NOT CITED] [LATEST Version]
  4. Bisphosphonates for advanced prostate cancer. PMID: 17054286 [NOT CITED] [OLD Version]
  5. Chemotherapy for hormone-refractory prostate cancer. PMID: 17054249 [NOT CITED] [LATEST Version]
  6. Cryotherapy for localised prostate cancer. PMID: 17636783 [NOT CITED] [LATEST Version]
  7. Decision aids for people facing health treatment or screening decisions. PMID: 11686990 [NOT CITED] [LATEST Version]
  8. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. PMID: 11869665 [NOT CITED] [LATEST Version]
  9. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer. PMID: 31194882 [NOT CITED] [LATEST Version]
  10. Exercise for the management of cancer-related fatigue in adults. PMID: 23152233 [NOT CITED] [LATEST Version]
  11. Five-alpha-reductase Inhibitors for prostate cancer prevention. PMID: 18425978 [CITED] [LATEST Version]
  12. Green and black tea for the primary prevention of cardiovascular disease. PMID: 23780706 [NOT CITED] [LATEST Version]
  13. Green tea (Camellia sinensis) for the prevention of cancer. PMID: 19588362 [NOT CITED] [LATEST Version]
  14. Hypofractionation for clinically localized prostate cancer. PMID: 31476800 [NOT CITED] [LATEST Version]
  15. Intermittent versus continuous androgen suppression for prostatic cancer. PMID: 17943832 [NOT CITED] [LATEST Version]
  16. Interventions for improving the adoption of shared decision making by healthcare professionals. PMID: 20464744 [NOT CITED] [LATEST Version]
  17. Interventions for managing medication-related osteonecrosis of the jaw. PMID: 28983908 [NOT CITED] [LATEST Version]
  18. Interventions for sexual dysfunction following treatments for cancer. PMID: 17943864 [NOT CITED] [LATEST Version]
  19. Interventions to enhance return-to-work for cancer patients. PMID: 26405010 [NOT CITED] [LATEST Version]
  20. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. PMID: 29360138 [NOT CITED] [LATEST Version]
  21. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. PMID: 28895658 [NOT CITED] [LATEST Version]
  22. Low-dose rate brachytherapy for men with localized prostate cancer. PMID: 21735436 [NOT CITED] [LATEST Version]
  23. Lycopene for the prevention of prostate cancer. PMID: 22071840 [NOT CITED] [LATEST Version]
  24. Maximal androgen blockade for advanced prostate cancer. PMID: 10796804 [NOT CITED] [LATEST Version]
  25. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. PMID: 17054269 [NOT CITED] [LATEST Version]
  26. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. PMID: 24979481 [NOT CITED] [LATEST Version]
  27. Penile rehabilitation for postprostatectomy erectile dysfunction. PMID: 30352488 [NOT CITED] [LATEST Version]
  28. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults. PMID: 29683475 [NOT CITED] [LATEST Version]
  29. Primary cryotherapy for localised or locally advanced prostate cancer. PMID: 29845595 [NOT CITED] [LATEST Version]
  30. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. PMID: 31022301 [NOT CITED] [LATEST Version]
  31. Psychosocial interventions for men with prostate cancer. PMID: 24368598 [NOT CITED] [LATEST Version]
  32. Radical prostatectomy versus watchful waiting for prostate cancer. PMID: 21069689 [CITED] [LATEST Version]
  33. Reiki for depression and anxiety. PMID: 25835541 [NOT CITED] [LATEST Version]
  34. Screening for prostate cancer. PMID: 23440794 [NOT CITED] [LATEST Version]
  35. Screening for prostate cancer. PMID: 16856057 [NOT CITED] [OLD Version]
  36. Screening for prostate cancer: shaping the debate on benefits and harms. PMID: 24475492 [NOT CITED] [LATEST Version]
  37. Selenium for preventing cancer. PMID: 29376219 [NOT CITED] [LATEST Version]
  38. Selenium for preventing cancer. PMID: 24683040 [NOT CITED] [OLD Version]
  39. Selenium for preventing cancer. PMID: 21563143 [NOT CITED] [OLD Version]
  40. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. PMID: 25261861 [NOT CITED] [LATEST Version]
  41. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. PMID: 21491408 [NOT CITED] [OLD Version]
  42. Systematic screening and assessment of psychosocial well-being and care needs of people with cancer. PMID: 30909317 [NOT CITED] [LATEST Version]
  43. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer. PMID: 30320443 [NOT CITED] [LATEST Version]
  44. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. PMID: 30556597 [NOT CITED] [LATEST Version]
234 Q128581 breast cancer Breast cancer B 1-Top

Hematology-oncology

Pathology
  1. Acupuncture for menopausal hot flushes. PMID: 23897589 [NOT CITED] [LATEST Version]
  2. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. PMID: 21069675 [NOT CITED] [LATEST Version]
  3. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. PMID: 16856005 [NOT CITED] [OLD Version]
  4. Antenatal breast examination for promoting breastfeeding. PMID: 18646135 [NOT CITED] [LATEST Version]
  5. Antibiotics / anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbs. PMID: 15106193 [NOT CITED] [LATEST Version]
  6. Antitumour antibiotic containing regimens for metastatic breast cancer. PMID: 15495049 [NOT CITED] [LATEST Version]
  7. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. PMID: 19821307 [NOT CITED] [LATEST Version]
  8. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. PMID: 17253488 [NOT CITED] [OLD Version]
  9. Automated telephone communication systems for preventive healthcare and management of long-term conditions. PMID: 27960229 [NOT CITED] [LATEST Version]
  10. Axillary treatment for operable primary breast cancer. PMID: 28052186 [NOT CITED] [LATEST Version]
  11. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. PMID: 15106192 [NOT CITED] [LATEST Version]
  12. Bioidentical hormones for women with vasomotor symptoms. PMID: 27479272 [NOT CITED] [LATEST Version]
  13. Bisphosphonates and other bone agents for breast cancer. PMID: 29082518 [NOT CITED] [LATEST Version]
  14. Bisphosphonates and other bone agents for breast cancer. PMID: 22336790 [NOT CITED] [OLD Version]
  15. Bisphosphonates for breast cancer. PMID: 16034900 [NOT CITED] [LATEST Version]
  16. Bisphosphonates for breast cancer. PMID: 11869664 [NOT CITED] [OLD Version]
  17. Breast surgery for metastatic breast cancer. PMID: 29542106 [NOT CITED] [LATEST Version]
  18. Cancer genetic risk assessment for individuals at risk of familial breast cancer. PMID: 22336791 [NOT CITED] [LATEST Version]
  19. Cancer genetic risk assessment for individuals at risk of familial breast cancer. PMID: 17443529 [NOT CITED] [OLD Version]
  20. Cardioprotective interventions for cancer patients receiving anthracyclines. PMID: 21678342 [NOT CITED] [LATEST Version]
  21. Cardioprotective interventions for cancer patients receiving anthracyclines. PMID: 18425895 [NOT CITED] [OLD Version]
  22. Cardioprotective interventions for cancer patients receiving anthracyclines. PMID: 15674919 [NOT CITED] [OLD Version]
  23. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer. PMID: 12804433 [NOT CITED] [LATEST Version]
  24. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. PMID: 17443560 [NOT CITED] [LATEST Version]
  25. Combination versus sequential single agent chemotherapy for metastatic breast cancer. PMID: 24347031 [NOT CITED] [LATEST Version]
  26. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy. PMID: 25677413 [NOT CITED] [LATEST Version]
  27. Dance/movement therapy for improving psychological and physical outcomes in cancer patients. PMID: 25565627 [NOT CITED] [LATEST Version]
  28. Dance/movement therapy for improving psychological and physical outcomes in cancer patients. PMID: 21975762 [NOT CITED] [OLD Version]
  29. Decision aids for people considering taking part in clinical trials. PMID: 26613337 [NOT CITED] [LATEST Version]
  30. Decision aids for people facing health treatment or screening decisions. PMID: 28402085 [NOT CITED] [LATEST Version]
  31. Different types of implants for reconstructive breast surgery. PMID: 27182693 [NOT CITED] [LATEST Version]
  32. Exercise for the management of cancer-related fatigue in adults. PMID: 23152233 [NOT CITED] [LATEST Version]
  33. Exercise for the management of cancer-related fatigue in adults. PMID: 18425939 [NOT CITED] [OLD Version]
  34. Exercise for women receiving adjuvant therapy for breast cancer. PMID: 27650122 [NOT CITED] [LATEST Version]
  35. Exercise for women receiving adjuvant therapy for breast cancer. PMID: 17054230 [NOT CITED] [OLD Version]
  36. Exercise interventions for people undergoing multimodal cancer treatment that includes surgery. PMID: 30536366 [NOT CITED] [LATEST Version]
  37. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. PMID: 20556760 [NOT CITED] [LATEST Version]
  38. Exercise interventions on health-related quality of life for cancer survivors. PMID: 22895961 [NOT CITED] [LATEST Version]
  39. Exercise interventions on health-related quality of life for people with cancer during active treatment. PMID: 22895974 [NOT CITED] [LATEST Version]
  40. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. PMID: 31204439 [NOT CITED] [LATEST Version]
  41. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. PMID: 23904353 [NOT CITED] [OLD Version]
  42. Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery. PMID: 23728694 [NOT CITED] [LATEST Version]
  43. Follow-up strategies for women treated for early breast cancer. PMID: 27230946 [NOT CITED] [LATEST Version]
  44. Follow-up strategies for women treated for early breast cancer. PMID: 15674884 [NOT CITED] [OLD Version]
  45. Follow-up strategies for women treated for early breast cancer. PMID: 11034727 [NOT CITED] [OLD Version]
  46. Fraction size in radiation therapy for breast conservation in early breast cancer. PMID: 27425588 [NOT CITED] [LATEST Version]
  47. Fraction size in radiation treatment for breast conservation in early breast cancer. PMID: 21069678 [NOT CITED] [LATEST Version]
  48. Fraction size in radiation treatment for breast conservation in early breast cancer. PMID: 18646095 [NOT CITED] [OLD Version]
  49. Fulvestrant for hormone-sensitive metastatic breast cancer. PMID: 28043088 [NOT CITED] [LATEST Version]
  50. Green tea (Camellia sinensis) for the prevention of cancer. PMID: 19588362 [NOT CITED] [LATEST Version]
  51. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. PMID: 16034886 [NOT CITED] [LATEST Version]
  52. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. PMID: 12535457 [NOT CITED] [OLD Version]
  53. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. PMID: 16034887 [NOT CITED] [LATEST Version]
  54. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. PMID: 12535458 [NOT CITED] [OLD Version]
  55. High dose, high risk? What updated evidence tells us about chemotherapy dosing in early breast cancer. PMID: 27241086 [NOT CITED] [LATEST Version]
  56. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. PMID: 27200512 [NOT CITED] [LATEST Version]
  57. Home-based multidimensional survivorship programmes for breast cancer survivors. PMID: 28836379 [NOT CITED] [LATEST Version]
  58. Homeopathic medicines for adverse effects of cancer treatments. PMID: 19370613 [NOT CITED] [LATEST Version]
  59. Hormone replacement therapy for women previously treated for endometrial cancer. PMID: 29763969 [NOT CITED] [LATEST Version]
  60. Immediate versus delayed reconstruction following surgery for breast cancer. PMID: 21735435 [NOT CITED] [LATEST Version]
  61. Interventions for promoting habitual exercise in people living with and beyond cancer. PMID: 30229557 [NOT CITED] [LATEST Version]
  62. Interventions for raising breast cancer awareness in women. PMID: 28185268 [NOT CITED] [LATEST Version]
  63. Interventions for relieving the pain and discomfort of screening mammography. PMID: 18254010 [NOT CITED] [LATEST Version]
  64. Interventions for relieving the pain and discomfort of screening mammography. PMID: 12519579 [NOT CITED] [OLD Version]
  65. Interventions for sexual dysfunction following treatments for cancer in women. PMID: 26830050 [NOT CITED] [LATEST Version]
  66. Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). PMID: 26919630 [NOT CITED] [LATEST Version]
  67. Interventions to enhance return-to-work for cancer patients. PMID: 26405010 [NOT CITED] [LATEST Version]
  68. Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews. PMID: 29406579 [NOT CITED] [LATEST Version]
  69. Lay health workers in primary and community health care. PMID: 15674924 [NOT CITED] [LATEST Version]
  70. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. PMID: 26649916 [NOT CITED] [LATEST Version]
  71. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. PMID: 19821400 [NOT CITED] [OLD Version]
  72. Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. PMID: 23737032 [NOT CITED] [LATEST Version]
  73. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. PMID: 19821328 [NOT CITED] [LATEST Version]
  74. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. PMID: 18843661 [NOT CITED] [OLD Version]
  75. Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery. PMID: 23076930 [NOT CITED] [LATEST Version]
  76. Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. PMID: 29926477 [NOT CITED] [LATEST Version]
  77. Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. PMID: 29694674 [NOT CITED] [OLD Version]
  78. Localization techniques for guided surgical excision of non-palpable breast lesions. PMID: 26718728 [NOT CITED] [LATEST Version]
  79. Long term hormone therapy for perimenopausal and postmenopausal women. PMID: 22786488 [NOT CITED] [LATEST Version]
  80. Long term hormone therapy for perimenopausal and postmenopausal women. PMID: 19370593 [NOT CITED] [OLD Version]
  81. Long term hormone therapy for perimenopausal and postmenopausal women. PMID: 16034922 [NOT CITED] [OLD Version]
  82. Long-term hormone therapy for perimenopausal and postmenopausal women. PMID: 28093732 [NOT CITED] [LATEST Version]
  83. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. PMID: 23633376 [NOT CITED] [LATEST Version]
  84. Manual lymphatic drainage for lymphedema following breast cancer treatment. PMID: 25994425 [NOT CITED] [LATEST Version]
  85. Massage with or without aromatherapy for symptom relief in people with cancer. PMID: 27258432 [NOT CITED] [LATEST Version]
  86. Methods of communicating a primary diagnosis of breast cancer to patients. PMID: 17636820 [NOT CITED] [LATEST Version]
  87. Mindfulness-based stress reduction for women diagnosed with breast cancer. PMID: 30916356 [NOT CITED] [LATEST Version]
  88. Mistletoe therapy in oncology. PMID: 18425885 [NOT CITED] [LATEST Version]
  89. Mobile clinics for women's and children's health. PMID: 27513824 [NOT CITED] [LATEST Version]
  90. Motivational interviewing for alcohol misuse in young adults. PMID: 25140980 [NOT CITED] [LATEST Version]
  91. Multi-agent chemotherapy for early breast cancer. PMID: 11869577 [NOT CITED] [LATEST Version]
  92. Multidisciplinary rehabilitation for follow-up of women treated for breast cancer. PMID: 23235677 [NOT CITED] [LATEST Version]
  93. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. PMID: 27898991 [NOT CITED] [LATEST Version]
  94. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome. PMID: 28257559 [NOT CITED] [LATEST Version]
  95. Non-hormonal interventions for hot flushes in women with a history of breast cancer. PMID: 20824841 [NOT CITED] [LATEST Version]
  96. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. PMID: 27529826 [NOT CITED] [LATEST Version]
  97. Oestrogen therapy for urinary incontinence in post-menopausal women. PMID: 23076892 [NOT CITED] [LATEST Version]
  98. Oestrogen therapy for urinary incontinence in post-menopausal women. PMID: 19821277 [NOT CITED] [OLD Version]
  99. Oestrogens for urinary incontinence in women. PMID: 12804406 [NOT CITED] [LATEST Version]
  100. Online support groups for women with breast cancer. PMID: 28278559 [NOT CITED] [LATEST Version]
  101. Oral and intrauterine progestogens for atypical endometrial hyperplasia. PMID: 30521671 [NOT CITED] [LATEST Version]
  102. Ovarian ablation for early breast cancer. PMID: 10796722 [NOT CITED] [OLD Version]
  103. Ovarian ablation for early breast cancer. PMID: 10908474 [NOT CITED] [LATEST Version]
  104. Partial breast irradiation for early breast cancer. PMID: 27425375 [NOT CITED] [LATEST Version]
  105. Partial breast irradiation for early breast cancer. PMID: 24938937 [NOT CITED] [OLD Version]
  106. Personalised risk communication for informed decision making about taking screening tests. PMID: 17054144 [NOT CITED] [LATEST Version]
  107. Pharmacological treatments for fatigue associated with palliative care. PMID: 21069692 [NOT CITED] [LATEST Version]
  108. Physical activity for women with breast cancer after adjuvant therapy. PMID: 29376559 [NOT CITED] [LATEST Version]
  109. Physical therapies for reducing and controlling lymphoedema of the limbs. PMID: 15495042 [NOT CITED] [LATEST Version]
  110. Phytoestrogens for menopausal vasomotor symptoms. PMID: 24323914 [NOT CITED] [LATEST Version]
  111. Phytoestrogens for vasomotor menopausal symptoms. PMID: 17943751 [NOT CITED] [LATEST Version]
  112. Platinum containing regimens for metastatic breast cancer. PMID: 15266482 [NOT CITED] [LATEST Version]
  113. Platinum containing regimens for metastatic breast cancer. PMID: 15106201 [NOT CITED] [OLD Version]
  114. Platinum-containing regimens for metastatic breast cancer. PMID: 28643430 [NOT CITED] [LATEST Version]
  115. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 24259251 [NOT CITED] [LATEST Version]
  116. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19821272 [NOT CITED] [OLD Version]
  117. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19588320 [NOT CITED] [OLD Version]
  118. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19160183 [NOT CITED] [OLD Version]
  119. Postoperative tamoxifen for ductal carcinoma in situ. PMID: 23076938 [NOT CITED] [LATEST Version]
  120. Preoperative chemotherapy for women with operable breast cancer. PMID: 17443564 [NOT CITED] [LATEST Version]
  121. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. PMID: 23076939 [NOT CITED] [LATEST Version]
  122. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. PMID: 26687844 [NOT CITED] [LATEST Version]
  123. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. PMID: 31557310 [NOT CITED] [LATEST Version]
  124. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. PMID: 24609957 [NOT CITED] [OLD Version]
  125. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. PMID: 22258962 [NOT CITED] [OLD Version]
  126. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. PMID: 16625637 [NOT CITED] [OLD Version]
  127. Prophylactic mastectomy for the prevention of breast cancer. PMID: 21069671 [NOT CITED] [LATEST Version]
  128. Prophylactic mastectomy for the prevention of breast cancer. PMID: 15495033 [NOT CITED] [OLD Version]
  129. Psychological interventions for women with metastatic breast cancer. PMID: 23737397 [NOT CITED] [LATEST Version]
  130. Psychological interventions for women with metastatic breast cancer. PMID: 18646104 [NOT CITED] [OLD Version]
  131. Psychological interventions for women with metastatic breast cancer. PMID: 15106244 [NOT CITED] [OLD Version]
  132. Psychological interventions for women with non-metastatic breast cancer. PMID: 26017383 [NOT CITED] [LATEST Version]
  133. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. PMID: 23152241 [NOT CITED] [LATEST Version]
  134. Radiotherapy for early breast cancer. PMID: 12076497 [NOT CITED] [LATEST Version]
  135. Regular self-examination or clinical examination for early detection of breast cancer. PMID: 12804462 [CITED] [LATEST Version]
  136. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. PMID: 30141832 [NOT CITED] [LATEST Version]
  137. Risk-reducing mastectomy for the prevention of primary breast cancer. PMID: 29620792 [CITED] [LATEST Version]
  138. Risk-reducing medications for primary breast cancer: a network meta-analysis. PMID: 31032883 [NOT CITED] [LATEST Version]
  139. School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18. PMID: 23450577 [NOT CITED] [LATEST Version]
  140. Screening for breast cancer with mammography. PMID: 23737396 [CITED] [LATEST Version]
  141. Screening for breast cancer with mammography. PMID: 21249649 [NOT CITED] [OLD Version]
  142. Screening for breast cancer with mammography. PMID: 19821284 [NOT CITED] [OLD Version]
  143. Screening for breast cancer with mammography. PMID: 17054145 [NOT CITED] [OLD Version]
  144. Screening for breast cancer with mammography. PMID: 11687128 [NOT CITED] [OLD Version]
  145. Screening for colorectal cancer using the faecal occult blood test, hemoccult. PMID: 10796760 [NOT CITED] [LATEST Version]
  146. Selenium for preventing cancer. PMID: 29376219 [NOT CITED] [LATEST Version]
  147. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. PMID: 30776132 [NOT CITED] [LATEST Version]
  148. Sequencing of chemotherapy and radiation therapy for early breast cancer. PMID: 17054248 [NOT CITED] [LATEST Version]
  149. Sequencing of chemotherapy and radiotherapy for early breast cancer. PMID: 23633328 [NOT CITED] [LATEST Version]
  150. Short and long term effects of tibolone in postmenopausal women. PMID: 22336846 [NOT CITED] [LATEST Version]
  151. Short-term and long-term effects of tibolone in postmenopausal women. PMID: 27733017 [NOT CITED] [LATEST Version]
  152. Single agent versus combination chemotherapy for metastatic breast cancer. PMID: 19370586 [NOT CITED] [LATEST Version]
  153. Single agent versus combination chemotherapy for metastatic breast cancer. PMID: 15846660 [NOT CITED] [OLD Version]
  154. Specialist breast care nurses for supportive care of women with breast cancer. PMID: 18254086 [NOT CITED] [LATEST Version]
  155. Strategies for increasing women participation in community breast cancer screening. PMID: 11279781 [NOT CITED] [LATEST Version]
  156. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). PMID: 16437480 [NOT CITED] [LATEST Version]
  157. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. PMID: 30779124 [NOT CITED] [LATEST Version]
  158. Systemic antibiotics for treating malignant wounds. PMID: 28837757 [NOT CITED] [LATEST Version]
  159. Systemic therapy for treating locoregional recurrence in women with breast cancer. PMID: 11687148 [NOT CITED] [LATEST Version]
  160. Tamoxifen for early breast cancer. PMID: 11279694 [NOT CITED] [LATEST Version]
  161. Tamoxifen for relapse of ovarian cancer. PMID: 20238312 [NOT CITED] [LATEST Version]
  162. Tamoxifen for relapse of ovarian cancer. PMID: 11279703 [NOT CITED] [OLD Version]
  163. Tamoxifen for relapse of ovarian cancer. PMID: 10796734 [NOT CITED] [OLD Version]
  164. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. PMID: 24213953 [NOT CITED] [LATEST Version]
  165. Taxane containing regimens for metastatic breast cancer. PMID: 15846659 [NOT CITED] [LATEST Version]
  166. Taxane containing regimens for metastatic breast cancer. PMID: 12917963 [NOT CITED] [OLD Version]
  167. Taxane-containing regimens for metastatic breast cancer. PMID: 26058962 [NOT CITED] [LATEST Version]
  168. Taxanes for adjuvant treatment of early breast cancer. PMID: 31476253 [NOT CITED] [LATEST Version]
  169. Taxanes for adjuvant treatment of early breast cancer. PMID: 17943815 [NOT CITED] [OLD Version]
  170. Timing of breast surgery in premenopausal breast cancer patients. PMID: 21563138 [NOT CITED] [LATEST Version]
  171. Topical agents and dressings for fungating wounds. PMID: 24832784 [NOT CITED] [LATEST Version]
  172. Topical agents and dressings for fungating wounds. PMID: 17443534 [NOT CITED] [OLD Version]
  173. Toremifene versus tamoxifen for advanced breast cancer. PMID: 22786516 [NOT CITED] [LATEST Version]
  174. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. PMID: 22419313 [NOT CITED] [LATEST Version]
  175. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. PMID: 18646140 [NOT CITED] [OLD Version]
  176. Trastuzumab containing regimens for early breast cancer. PMID: 22513938 [NOT CITED] [LATEST Version]
  177. Trastuzumab-containing regimens for metastatic breast cancer. PMID: 24919460 [NOT CITED] [LATEST Version]
  178. Treating metastatic breast cancer: the evidence for targeted therapy. PMID: 25032250 [NOT CITED] [LATEST Version]
  179. Tumour bed boost radiotherapy for women after breast-conserving surgery. PMID: 29105051 [NOT CITED] [LATEST Version]
  180. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer. PMID: 22786517 [NOT CITED] [LATEST Version]
  181. Wound drainage after axillary dissection for carcinoma of the breast. PMID: 24158902 [NOT CITED] [LATEST Version]
  182. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. PMID: 28045199 [NOT CITED] [LATEST Version]
542 Q160105 cervical cancer Cervical cancer B 1-Top

Hematology-oncology

Pathology

Reproductive medicine
  1. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. PMID: 25470408 [NOT CITED] [LATEST Version]
  2. Adjuvant platinum-based chemotherapy for early stage cervical cancer. PMID: 27873308 [CITED] [LATEST Version]
  3. Adjuvant platinum-based chemotherapy for early stage cervical cancer. PMID: 22696349 [NOT CITED] [OLD Version]
  4. Adjuvant platinum-based chemotherapy for early stage cervical cancer. PMID: 19588370 [NOT CITED] [OLD Version]
  5. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer. PMID: 19821430 [NOT CITED] [LATEST Version]
  6. Antibiotics for infection prevention after excision of the cervical transformation zone. PMID: 28109160 [NOT CITED] [LATEST Version]
  7. Automated telephone communication systems for preventive healthcare and management of long-term conditions. PMID: 27960229 [NOT CITED] [LATEST Version]
  8. Chemotherapy for metastatic and recurrent cervical cancer. PMID: 23076924 [NOT CITED] [LATEST Version]
  9. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. PMID: 16034873 [NOT CITED] [LATEST Version]
  10. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. PMID: 11687152 [NOT CITED] [OLD Version]
  11. Cytology versus HPV testing for cervical cancer screening in the general population. PMID: 28796882 [NOT CITED] [LATEST Version]
  12. Extended-field radiotherapy for locally advanced cervical cancer. PMID: 30362204 [NOT CITED] [LATEST Version]
  13. Follow-up protocols for women with cervical cancer after primary treatment. PMID: 24277645 [NOT CITED] [LATEST Version]
  14. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test. PMID: 25562623 [NOT CITED] [LATEST Version]
  15. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 25300170 [NOT CITED] [LATEST Version]
  16. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 20614461 [NOT CITED] [OLD Version]
  17. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. PMID: 23543559 [NOT CITED] [LATEST Version]
  18. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. PMID: 25847525 [NOT CITED] [LATEST Version]
  19. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test. PMID: 28125861 [NOT CITED] [LATEST Version]
  20. Interventions for encouraging sexual behaviours intended to prevent cervical cancer. PMID: 21491379 [NOT CITED] [LATEST Version]
  21. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer. PMID: 10796735 [NOT CITED] [LATEST Version]
  22. Interventions for reducing anxiety in women undergoing colposcopy. PMID: 22161395 [NOT CITED] [LATEST Version]
  23. Interventions for reducing anxiety in women undergoing colposcopy. PMID: 17636821 [NOT CITED] [OLD Version]
  24. Interventions for sexual dysfunction following treatments for cancer. PMID: 17943864 [NOT CITED] [LATEST Version]
  25. Interventions targeted at women to encourage the uptake of cervical screening. PMID: 21563135 [CITED] [LATEST Version]
  26. Interventions targeted at women to encourage the uptake of cervical screening. PMID: 12137660 [NOT CITED] [OLD Version]
  27. Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer. PMID: 24085528 [NOT CITED] [LATEST Version]
  28. Neoadjuvant chemotherapy for locally advanced cervix cancer. PMID: 15106161 [NOT CITED] [LATEST Version]
  29. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. PMID: 23235641 [NOT CITED] [LATEST Version]
  30. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. PMID: 20091632 [NOT CITED] [OLD Version]
  31. Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa). PMID: 30746689 [NOT CITED] [LATEST Version]
  32. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. PMID: 29095502 [NOT CITED] [LATEST Version]
  33. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 30888060 [NOT CITED] [LATEST Version]
  34. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 25932968 [NOT CITED] [OLD Version]
  35. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. PMID: 23543561 [NOT CITED] [LATEST Version]
  36. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. PMID: 21491407 [NOT CITED] [OLD Version]
  37. Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. PMID: 20091590 [NOT CITED] [LATEST Version]
  38. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. PMID: 23440805 [CITED] [LATEST Version]
  39. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. PMID: 29740819 [NOT CITED] [LATEST Version]
  40. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. PMID: 25267916 [NOT CITED] [OLD Version]
  41. Radiotherapy and chemoradiation after surgery for early cervical cancer. PMID: 22592722 [NOT CITED] [LATEST Version]
  42. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. PMID: 20091664 [NOT CITED] [LATEST Version]
  43. Robotic assisted surgery for gynaecological cancer. PMID: 22258988 [NOT CITED] [LATEST Version]
  44. Screening programmes for the early detection and prevention of oral cancer. PMID: 16856035 [NOT CITED] [LATEST Version]
  45. Surgical treatment of stage IA2 cervical cancer. PMID: 24874726 [NOT CITED] [LATEST Version]
  46. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer. PMID: 30311942 [NOT CITED] [LATEST Version]
349 Q185034 sickle-cell disease Sickle cell disease B 2-High

Hematology-oncology

Medical genetics
  1. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. PMID: 26041152 [NOT CITED] [LATEST Version]
  2. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. PMID: 23543572 [NOT CITED] [OLD Version]
  3. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under. PMID: 26408070 [NOT CITED] [LATEST Version]
  4. Antibiotics for treating acute chest syndrome in people with sickle cell disease. PMID: 31531967 [NOT CITED] [LATEST Version]
  5. Antibiotics for treating acute chest syndrome in people with sickle cell disease. PMID: 25749695 [NOT CITED] [OLD Version]
  6. Antibiotics for treating acute chest syndrome in people with sickle cell disease. PMID: 23440803 [NOT CITED] [OLD Version]
  7. Antibiotics for treating acute chest syndrome in people with sickle cell disease. PMID: 17443613 [NOT CITED] [OLD Version]
  8. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. PMID: 23076916 [NOT CITED] [LATEST Version]
  9. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. PMID: 16856106 [NOT CITED] [OLD Version]
  10. Antibiotics for treating community-acquired pneumonia in people with sickle cell disease. PMID: 27841444 [NOT CITED] [LATEST Version]
  11. Antibiotics for treating osteomyelitis in people with sickle cell disease. PMID: 27841931 [NOT CITED] [LATEST Version]
  12. Antibiotics for treating osteomyelitis in people with sickle cell disease. PMID: 23235640 [NOT CITED] [OLD Version]
  13. Antibiotics for treating osteomyelitis in people with sickle cell disease. PMID: 19370676 [NOT CITED] [OLD Version]
  14. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. PMID: 28094851 [NOT CITED] [LATEST Version]
  15. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. PMID: 24226646 [NOT CITED] [OLD Version]
  16. Blood transfusion for preventing stroke in people with sickle cell disease. PMID: 11869654 [NOT CITED] [LATEST Version]
  17. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. PMID: 27574910 [NOT CITED] [LATEST Version]
  18. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. PMID: 20091653 [NOT CITED] [OLD Version]
  19. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. PMID: 30125338 [NOT CITED] [LATEST Version]
  20. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. PMID: 26881484 [NOT CITED] [OLD Version]
  21. Deferasirox for managing transfusional iron overload in people with sickle cell disease. PMID: 24893174 [NOT CITED] [LATEST Version]
  22. Deferasirox for managing transfusional iron overload in people with sickle cell disease. PMID: 20687088 [NOT CITED] [OLD Version]
  23. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 30338520 [NOT CITED] [LATEST Version]
  24. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 26942338 [NOT CITED] [OLD Version]
  25. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 22786485 [NOT CITED] [OLD Version]
  26. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 20091545 [NOT CITED] [OLD Version]
  27. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 17943791 [NOT CITED] [OLD Version]
  28. Drugs for preventing red blood cell dehydration in people with sickle cell disease. PMID: 12519597 [NOT CITED] [OLD Version]
  29. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. PMID: 28759112 [NOT CITED] [LATEST Version]
  30. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. PMID: 25764071 [NOT CITED] [OLD Version]
  31. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. PMID: 22696351 [NOT CITED] [OLD Version]
  32. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. PMID: 17443589 [NOT CITED] [OLD Version]
  33. Folate supplementation in people with sickle cell disease. PMID: 29546732 [CITED] [LATEST Version]
  34. Folate supplementation in people with sickle cell disease. PMID: 26880182 [NOT CITED] [OLD Version]
  35. Gene therapy for sickle cell disease. PMID: 30480767 [CITED] [LATEST Version]
  36. Gene therapy for sickle cell disease. PMID: 27841932 [NOT CITED] [OLD Version]
  37. Gene therapy for sickle cell disease. PMID: 25300171 [NOT CITED] [OLD Version]
  38. Gene therapy for sickle cell disease. PMID: 23152248 [NOT CITED] [OLD Version]
  39. Gene therapy for sickle cell disease. PMID: 20687090 [NOT CITED] [OLD Version]
  40. Hematopoietic stem cell transplantation for children with sickle cell disease. PMID: 19160312 [NOT CITED] [LATEST Version]
  41. Hematopoietic stem cell transplantation for people with sickle cell disease. PMID: 27194464 [NOT CITED] [LATEST Version]
  42. Hematopoietic stem cell transplantation for people with sickle cell disease. PMID: 23728664 [NOT CITED] [OLD Version]
  43. Hydroxyurea (hydroxycarbamide) for sickle cell disease. PMID: 28426137 [NOT CITED] [LATEST Version]
  44. Hydroxyurea for sickle cell disease. PMID: 11406036 [NOT CITED] [LATEST Version]
  45. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. PMID: 27673392 [NOT CITED] [LATEST Version]
  46. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. PMID: 25086371 [NOT CITED] [OLD Version]
  47. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. PMID: 22786487 [NOT CITED] [OLD Version]
  48. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. PMID: 12917983 [NOT CITED] [OLD Version]
  49. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. PMID: 18254121 [NOT CITED] [LATEST Version]
  50. Interventions for chronic kidney disease in people with sickle cell disease. PMID: 28672087 [NOT CITED] [LATEST Version]
  51. Interventions for chronic kidney disease in people with sickle cell disease. PMID: 28344511 [NOT CITED] [OLD Version]
  52. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. PMID: 29737522 [NOT CITED] [LATEST Version]
  53. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. PMID: 27713668 [NOT CITED] [OLD Version]
  54. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications. PMID: 27711980 [NOT CITED] [LATEST Version]
  55. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. PMID: 28500860 [NOT CITED] [LATEST Version]
  56. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. PMID: 28344510 [NOT CITED] [OLD Version]
  57. Interventions for treating intrahepatic cholestasis in people with sickle cell disease. PMID: 28759700 [NOT CITED] [LATEST Version]
  58. Interventions for treating intrahepatic cholestasis in people with sickle cell disease. PMID: 25769029 [NOT CITED] [OLD Version]
  59. Interventions for treating leg ulcers in people with sickle cell disease. PMID: 25485858 [NOT CITED] [LATEST Version]
  60. Interventions for treating leg ulcers in people with sickle cell disease. PMID: 23152256 [NOT CITED] [OLD Version]
  61. Interventions for treating neuropathic pain in people with sickle cell disease. PMID: 31273755 [NOT CITED] [LATEST Version]
  62. Interventions for treating painful sickle cell crisis during pregnancy. PMID: 19160301 [NOT CITED] [LATEST Version]
  63. Laser therapy for retinopathy in sickle cell disease. PMID: 26451693 [NOT CITED] [LATEST Version]
  64. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. PMID: 26684281 [NOT CITED] [LATEST Version]
  65. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. PMID: 23760785 [NOT CITED] [OLD Version]
  66. Magnesium for treating sickle cell disease. PMID: 31498421 [NOT CITED] [LATEST Version]
  67. Magnesium for treating sickle cell disease. PMID: 28409830 [NOT CITED] [OLD Version]
  68. Malaria chemoprophylaxis in sickle cell disease. PMID: 17054173 [CITED] [LATEST Version]
  69. Malaria chemoprophylaxis in sickle cell disease. PMID: 12917969 [NOT CITED] [OLD Version]
  70. Neonatal screening for sickle cell disease. PMID: 10796837 [NOT CITED] [LATEST Version]
  71. Oral deferiprone for iron chelation in people with thalassaemia. PMID: 23966105 [NOT CITED] [LATEST Version]
  72. Pain management for sickle cell disease. PMID: 16625580 [NOT CITED] [LATEST Version]
  73. Phytomedicines (medicines derived from plants) for sickle cell disease. PMID: 29446825 [NOT CITED] [LATEST Version]
  74. Phytomedicines (medicines derived from plants) for sickle cell disease. PMID: 25844571 [NOT CITED] [OLD Version]
  75. Phytomedicines (medicines derived from plants) for sickle cell disease. PMID: 23440792 [NOT CITED] [OLD Version]
  76. Phytomedicines (medicines derived from plants) for sickle cell disease. PMID: 20927735 [NOT CITED] [OLD Version]
  77. Phytomedicines (medicines derived from plants) for sickle cell disease. PMID: 15266534 [NOT CITED] [OLD Version]
  78. Piracetam for reducing the incidence of painful sickle cell disease crises. PMID: 26869149 [NOT CITED] [LATEST Version]
  79. Piracetam for reducing the incidence of painful sickle cell disease crises. PMID: 17443614 [NOT CITED] [OLD Version]
  80. Pneumococcal vaccines for sickle cell disease. PMID: 14974042 [NOT CITED] [LATEST Version]
  81. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. PMID: 29537064 [NOT CITED] [LATEST Version]
  82. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. PMID: 26264938 [NOT CITED] [OLD Version]
  83. Preoperative blood transfusions for sickle cell disease. PMID: 27049331 [NOT CITED] [LATEST Version]
  84. Preoperative blood transfusions for sickle cell disease. PMID: 22258951 [NOT CITED] [OLD Version]
  85. Preoperative blood transfusions for sickle cell disease. PMID: 11687042 [NOT CITED] [OLD Version]
  86. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. PMID: 28994899 [NOT CITED] [LATEST Version]
  87. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. PMID: 25375222 [NOT CITED] [OLD Version]
  88. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. PMID: 22972063 [NOT CITED] [OLD Version]
  89. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. PMID: 12137693 [NOT CITED] [OLD Version]
  90. Prophylactic versus selective blood transfusion for sickle cell anaemia during pregnancy. PMID: 10796098 [NOT CITED] [LATEST Version]
  91. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. PMID: 28005272 [NOT CITED] [LATEST Version]
  92. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. PMID: 24297507 [NOT CITED] [OLD Version]
  93. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents. PMID: 30939227 [NOT CITED] [LATEST Version]
  94. Psychological therapies for sickle cell disease and pain. PMID: 25966336 [CITED] [LATEST Version]
  95. Psychological therapies for sickle cell disease and pain. PMID: 22336781 [NOT CITED] [OLD Version]
  96. Psychological therapies for sickle cell disease and pain. PMID: 12076428 [NOT CITED] [OLD Version]
  97. Psychological therapies for sickle cell disease and pain. PMID: 10908516 [NOT CITED] [OLD Version]
  98. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. PMID: 30270423 [NOT CITED] [LATEST Version]
  99. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. PMID: 24796681 [NOT CITED] [OLD Version]
  100. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. PMID: 23235601 [NOT CITED] [OLD Version]
  101. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. PMID: 19370592 [NOT CITED] [OLD Version]
  102. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews. PMID: 30067867 [NOT CITED] [LATEST Version]
  103. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews. PMID: 27069421 [NOT CITED] [OLD Version]
  104. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 27198469 [NOT CITED] [LATEST Version]
  105. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 24399756 [NOT CITED] [OLD Version]
  106. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 21901721 [NOT CITED] [OLD Version]
  107. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. PMID: 29112240 [NOT CITED] [LATEST Version]
  108. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. PMID: 26344060 [NOT CITED] [OLD Version]
  109. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. PMID: 23728644 [NOT CITED] [OLD Version]
  110. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. PMID: 12519596 [NOT CITED] [OLD Version]
  111. Steroid hormones for contraception in women with sickle cell disease. PMID: 17443618 [NOT CITED] [LATEST Version]
  112. Transfusion of red blood cells stored for shorter versus longer duration for all conditions. PMID: 30578732 [NOT CITED] [LATEST Version]
  113. Treatment for avascular necrosis of bone in people with sickle cell disease. PMID: 27502327 [CITED] [LATEST Version]
  114. Treatment for avascular necrosis of bone in people with sickle cell disease. PMID: 25009086 [NOT CITED] [OLD Version]
  115. Treatment for avascular necrosis of bone in people with sickle cell disease. PMID: 22592696 [NOT CITED] [OLD Version]
  116. Treatment for avascular necrosis of bone in people with sickle cell disease. PMID: 19588352 [NOT CITED] [OLD Version]
  117. Treatment for avascular necrosis of bone in people with sickle cell disease. PMID: 15495103 [NOT CITED] [OLD Version]
  118. Treatment of dental complications in sickle cell disease. PMID: 27103509 [NOT CITED] [LATEST Version]
  119. Treatments for priapism in boys and men with sickle cell disease. PMID: 28926088 [NOT CITED] [LATEST Version]
  120. Treatments for priapism in boys and men with sickle cell disease. PMID: 15495085 [NOT CITED] [OLD Version]
  121. Vaccines for preventing invasive salmonella infections in people with sickle cell disease. PMID: 30521695 [NOT CITED] [LATEST Version]
  122. Vaccines for preventing invasive salmonella infections in people with sickle cell disease. PMID: 26043710 [NOT CITED] [OLD Version]
  123. Vaccines for preventing invasive salmonella infections in people with sickle cell disease. PMID: 19821392 [NOT CITED] [OLD Version]
  124. Vitamin D supplementation for sickle cell disease. PMID: 28105733 [NOT CITED] [LATEST Version]
  125. Zinc supplements for treating thalassaemia and sickle cell disease. PMID: 23807756 [NOT CITED] [LATEST Version]
353 Q223911 sarcoma Sarcoma Start 2-High

Hematology-oncology
  1. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. PMID: 11034717 [NOT CITED] [LATEST Version]
  2. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC). PMID: 10796873 [NOT CITED] [LATEST Version]
  3. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma. PMID: 23450567 [NOT CITED] [LATEST Version]
  4. Corticosteroids for tuberculous pleurisy. PMID: 28290161 [NOT CITED] [LATEST Version]
  5. Corticosteroids for tuberculous pleurisy. PMID: 17943759 [NOT CITED] [OLD Version]
  6. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. PMID: 12917946 [NOT CITED] [LATEST Version]
  7. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. PMID: 26421585 [NOT CITED] [LATEST Version]
  8. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. PMID: 23235629 [NOT CITED] [OLD Version]
  9. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. PMID: 20166081 [NOT CITED] [OLD Version]
  10. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. PMID: 12917960 [NOT CITED] [LATEST Version]
  11. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. PMID: 28654140 [NOT CITED] [LATEST Version]
  12. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. PMID: 21154373 [NOT CITED] [LATEST Version]
  13. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 25188452 [NOT CITED] [LATEST Version]
  14. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 21249679 [NOT CITED] [OLD Version]
  15. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 19160293 [NOT CITED] [OLD Version]
  16. Treatment of Kaposi sarcoma in children with HIV-1 infection. PMID: 24464843 [NOT CITED] [LATEST Version]
  17. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings. PMID: 12917957 [NOT CITED] [LATEST Version]
  18. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. PMID: 25221796 [NOT CITED] [OLD Version]
  19. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. PMID: 25313415 [NOT CITED] [LATEST Version]
1896 Q3658562 non-small-cell lung carcinoma Non-small-cell lung carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology
  1. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. PMID: 17943820 [NOT CITED] [LATEST Version]
381 Q233309 brain tumor Brain tumor C 2-High

Hematology-oncology

Neurology
  1. Antiepileptic drugs for preventing seizures in people with brain tumors. PMID: 18425902 [NOT CITED] [LATEST Version]
  2. Whole brain radiotherapy for the treatment of multiple brain metastases. PMID: 16856022 [NOT CITED] [LATEST Version]
4311 Q5445 anemia Anemia B 2-High

Hematology-oncology
  1. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. PMID: 26041152 [NOT CITED] [LATEST Version]
  2. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. PMID: 23543572 [NOT CITED] [OLD Version]
  3. Chemotherapy for advanced non-small cell lung cancer in the elderly population. PMID: 26482542 [NOT CITED] [LATEST Version]
  4. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856062 [NOT CITED] [LATEST Version]
  5. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. PMID: 25356860 [NOT CITED] [LATEST Version]
  6. Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age. PMID: 30779870 [NOT CITED] [LATEST Version]
  7. Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis. PMID: 23450527 [NOT CITED] [LATEST Version]
  8. Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. PMID: 19588423 [NOT CITED] [LATEST Version]
  9. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. PMID: 23881658 [NOT CITED] [LATEST Version]
  10. Hydralazine for essential hypertension. PMID: 22071816 [NOT CITED] [LATEST Version]
  11. Hydralazine for essential hypertension. PMID: 20687078 [NOT CITED] [OLD Version]
  12. Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia. PMID: 30882896 [NOT CITED] [LATEST Version]
  13. Iron for restless legs syndrome. PMID: 22592724 [NOT CITED] [LATEST Version]
  14. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis. PMID: 25860512 [NOT CITED] [LATEST Version]
  15. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856064 [NOT CITED] [LATEST Version]
  16. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. PMID: 12804504 [NOT CITED] [LATEST Version]
  17. Pegloticase for chronic gout. PMID: 20238366 [NOT CITED] [LATEST Version]
  18. Purine antagonists for chronic lymphocytic leukaemia. PMID: 16856041 [NOT CITED] [LATEST Version]
  19. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. PMID: 26845108 [NOT CITED] [LATEST Version]
  20. Treatment for anemia in people with AIDS. PMID: 21975747 [NOT CITED] [LATEST Version]
  21. Treatment for anemia in people with AIDS. PMID: 17253523 [NOT CITED] [OLD Version]
  22. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer. PMID: 20556770 [NOT CITED] [LATEST Version]
  23. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. PMID: 14583988 [NOT CITED] [LATEST Version]
  24. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. PMID: 12917978 [NOT CITED] [OLD Version]
2546 Q6708247 Lymphoblastic lymphoma Lymphoblastic lymphoma C 2-High

Hematology-oncology

 No matching publication found!
521 Q264118 acute myeloid leukemia Acute myeloid leukemia FA 2-High

Hematology-oncology
  1. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 21833963 [NOT CITED] [LATEST Version]
  2. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 26107113 [NOT CITED] [LATEST Version]
2078 Q6488975 large-cell lung carcinoma Large-cell lung carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
1501 Q3242950 kidney cancer Kidney cancer C 2-High

Hematology-oncology

 No matching publication found!
4197 Q843799 adenocarcinoma of the lung Adenocarcinoma of the lung C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
2974 Q1762339 deep vein thrombosis Deep vein thrombosis GA 2-High

Cardiology

Hematology-oncology
  1. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 25386666 [NOT CITED] [LATEST Version]
  2. Anaesthesia for hip fracture surgery in adults. PMID: 26899415 [NOT CITED] [LATEST Version]
  3. Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy. PMID: 20556784 [NOT CITED] [LATEST Version]
  4. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. PMID: 27027384 [NOT CITED] [LATEST Version]
  5. Anticoagulants for acute ischaemic stroke. PMID: 25764172 [NOT CITED] [LATEST Version]
  6. Anticoagulants for acute ischaemic stroke. PMID: 18843603 [NOT CITED] [OLD Version]
  7. Anticoagulants for acute ischaemic stroke. PMID: 15266421 [NOT CITED] [OLD Version]
  8. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. PMID: 12519590 [NOT CITED] [LATEST Version]
  9. Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. PMID: 16437461 [CITED] [LATEST Version]
  10. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. PMID: 27643712 [NOT CITED] [LATEST Version]
  11. Antifibrinolytic drugs for acute traumatic injury. PMID: 25956410 [NOT CITED] [LATEST Version]
  12. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. PMID: 30004572 [NOT CITED] [LATEST Version]
  13. Antithrombotic treatment after stroke due to intracerebral haemorrhage. PMID: 28540976 [NOT CITED] [LATEST Version]
  14. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. PMID: 18843686 [CITED] [LATEST Version]
  15. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. PMID: 27600864 [NOT CITED] [LATEST Version]
  16. Compression stockings for preventing deep vein thrombosis in airline passengers. PMID: 27624857 [NOT CITED] [LATEST Version]
  17. Compression stockings for preventing deep vein thrombosis in airline passengers. PMID: 16625594 [CITED] [OLD Version] [UPDATE NEEDED]
  18. Compression therapy for prevention of post-thrombotic syndrome. PMID: 28950030 [NOT CITED] [LATEST Version]
  19. Compression therapy for treating post-thrombotic syndrome. PMID: 31531971 [NOT CITED] [LATEST Version]
  20. Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome. PMID: 14584008 [NOT CITED] [LATEST Version]
  21. Continuous versus intermittent physiological monitoring for acute stroke. PMID: 23728675 [NOT CITED] [LATEST Version]
  22. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. PMID: 25528992 [NOT CITED] [LATEST Version]
  23. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. PMID: 23152279 [NOT CITED] [OLD Version]
  24. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization. PMID: 24590623 [NOT CITED] [LATEST Version]
  25. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE. PMID: 25749503 [NOT CITED] [LATEST Version]
  26. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 28832905 [NOT CITED] [LATEST Version]
  27. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 30407621 [NOT CITED] [LATEST Version]
  28. Elastic compression stockings for prevention of deep vein thrombosis. PMID: 20614425 [NOT CITED] [LATEST Version]
  29. Elastic compression stockings for prevention of deep vein thrombosis. PMID: 10908501 [NOT CITED] [OLD Version]
  30. Graduated compression stockings for prevention of deep vein thrombosis. PMID: 30390397 [CITED] [LATEST Version]
  31. Graduated compression stockings for prevention of deep vein thrombosis. PMID: 25517473 [NOT CITED] [OLD Version]
  32. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). PMID: 24804622 [CITED] [LATEST Version]
  33. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). PMID: 19588346 [NOT CITED] [LATEST Version]
  34. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. PMID: 12519540 [NOT CITED] [LATEST Version]
  35. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. PMID: 10796339 [NOT CITED] [OLD Version]
  36. Home versus in-patient treatment for deep vein thrombosis. PMID: 29315455 [NOT CITED] [LATEST Version]
  37. Home versus in-patient treatment for deep vein thrombosis. PMID: 17636714 [NOT CITED] [OLD Version]
  38. Home versus in-patient treatment for deep vein thrombosis. PMID: 11406067 [NOT CITED] [OLD Version]
  39. Interventions for lowering plasma homocysteine levels in dialysis patients. PMID: 27243372 [NOT CITED] [LATEST Version]
  40. Interventions for preventing venous thromboembolism following abdominal aortic surgery. PMID: 18254082 [NOT CITED] [LATEST Version]
  41. Interventions for varicose veins and leg oedema in pregnancy. PMID: 26477632 [NOT CITED] [LATEST Version]
  42. Interventions for varicose veins and leg oedema in pregnancy. PMID: 17253454 [NOT CITED] [OLD Version]
  43. Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients. PMID: 22592717 [NOT CITED] [LATEST Version]
  44. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. PMID: 24615288 [NOT CITED] [LATEST Version]
  45. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 28374884 [NOT CITED] [LATEST Version]
  46. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 18646059 [NOT CITED] [OLD Version]
  47. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 15846600 [NOT CITED] [OLD Version]
  48. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 11687069 [NOT CITED] [OLD Version]
  49. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 10796301 [NOT CITED] [OLD Version]
  50. Neuromuscular electrical stimulation for the prevention of venous thromboembolism. PMID: 29161465 [NOT CITED] [LATEST Version]
  51. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. PMID: 14974060 [NOT CITED] [LATEST Version]
  52. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. PMID: 29285754 [NOT CITED] [LATEST Version]
  53. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. PMID: 26123214 [NOT CITED] [LATEST Version]
  54. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. PMID: 26636644 [NOT CITED] [LATEST Version]
  55. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 28892556 [NOT CITED] [LATEST Version]
  56. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 25491949 [NOT CITED] [OLD Version]
  57. Pedicle screw fixation for traumatic fractures of the thoracic and lumbar spine. PMID: 23728686 [NOT CITED] [LATEST Version]
  58. Pentasaccharides for the treatment of deep vein thrombosis. PMID: 29199766 [NOT CITED] [LATEST Version]
  59. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis. PMID: 27814432 [NOT CITED] [LATEST Version]
  60. Physical methods for preventing deep vein thrombosis in stroke. PMID: 20687069 [NOT CITED] [LATEST Version]
  61. Physical methods for preventing deep vein thrombosis in stroke. PMID: 15495020 [NOT CITED] [OLD Version]
  62. Physical methods for preventing deep vein thrombosis in stroke. PMID: 11869611 [NOT CITED] [OLD Version]
  63. Postoperative tamoxifen for ductal carcinoma in situ. PMID: 23076938 [NOT CITED] [LATEST Version]
  64. Pre-operative education for hip or knee replacement. PMID: 14974019 [NOT CITED] [LATEST Version]
  65. Preoperative education for hip or knee replacement. PMID: 24820247 [NOT CITED] [LATEST Version]
  66. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity. PMID: 24343728 [NOT CITED] [LATEST Version]
  67. Rutosides for prevention of post-thrombotic syndrome. PMID: 30406639 [NOT CITED] [LATEST Version]
  68. Statins for primary prevention of venous thromboembolism. PMID: 25518837 [CITED] [LATEST Version]
  69. Statins for primary prevention of venous thromboembolism. PMID: 22161421 [NOT CITED] [OLD Version]
  70. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. PMID: 28195640 [NOT CITED] [LATEST Version]
  71. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. PMID: 19821386 [NOT CITED] [OLD Version]
  72. Thrombolysis for acute deep vein thrombosis. PMID: 27830895 [CITED] [LATEST Version]
  73. Thrombolysis for acute deep vein thrombosis. PMID: 24452314 [CITED] [OLD Version] [UPDATE NEEDED]
  74. Thrombolysis for acute deep vein thrombosis. PMID: 15495034 [NOT CITED] [OLD Version]
  75. Thrombolysis for acute upper extremity deep vein thrombosis. PMID: 29226949 [NOT CITED] [LATEST Version]
  76. Thromboprophylaxis for trauma patients. PMID: 23543562 [NOT CITED] [LATEST Version]
  77. Topical application of tranexamic acid for the reduction of bleeding. PMID: 23881695 [NOT CITED] [LATEST Version]
  78. Tranexamic acid for reducing mortality in emergency and urgent surgery. PMID: 23440847 [NOT CITED] [LATEST Version]
  79. Treatment for femoral pseudoaneurysms. PMID: 24293322 [NOT CITED] [LATEST Version]
  80. Treatment for femoral pseudoaneurysms. PMID: 19370614 [NOT CITED] [OLD Version]
  81. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 22972111 [NOT CITED] [LATEST Version]
  82. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 28431186 [NOT CITED] [LATEST Version]
  83. Vena caval filters for the prevention of pulmonary embolism. PMID: 20166079 [CITED] [LATEST Version]
  84. Vena caval filters for the prevention of pulmonary embolism. PMID: 17943896 [NOT CITED] [OLD Version]
  85. Vena caval filters for the prevention of pulmonary embolism. PMID: 17636834 [NOT CITED] [OLD Version]
  86. Very early versus delayed mobilisation after stroke. PMID: 30321906 [NOT CITED] [LATEST Version]
  87. Very early versus delayed mobilisation after stroke. PMID: 19160268 [NOT CITED] [OLD Version]
  88. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. PMID: 23076894 [NOT CITED] [LATEST Version]
699 Q5097982 childhood leukemia Childhood leukemia B 2-High

Hematology-oncology

 No matching publication found!
2417 Q738170 small cell carcinoma Small-cell carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
3349 Q1712331 Rh disease Rh disease B 2-High

Hematology-oncology

 No matching publication found!
2813 Q7315926 respiratory system cancer Respiratory tract neoplasm B 2-High

Hematology-oncology

 No matching publication found!
284 Q423965 Vestibular schwannoma Vestibular schwannoma B 2-High

Dermatology

Hematology-oncology

Neurology
  1. Stereotactic radiotherapy for vestibular schwannoma. PMID: 25511415 [CITED] [LATEST Version]
4536 Q29496 leukemia Leukemia B 2-High

Hematology-oncology
  1. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. PMID: 21975786 [NOT CITED] [LATEST Version]
  2. Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas. PMID: 28407197 [NOT CITED] [LATEST Version]
  3. Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk. PMID: 16235316 [NOT CITED] [LATEST Version]
  4. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia. PMID: 22696376 [NOT CITED] [LATEST Version]
  5. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia. PMID: 21901718 [NOT CITED] [OLD Version]
  6. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 21833963 [NOT CITED] [LATEST Version]
  7. Early versus deferred treatment for early stage multiple myeloma. PMID: 12535504 [NOT CITED] [LATEST Version]
  8. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. PMID: 25356860 [NOT CITED] [LATEST Version]
  9. Interventions for improving communication with children and adolescents about their cancer. PMID: 12917938 [NOT CITED] [LATEST Version]
  10. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis. PMID: 25860512 [NOT CITED] [LATEST Version]
  11. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 25269391 [NOT CITED] [LATEST Version]
  12. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission. PMID: 23543579 [NOT CITED] [LATEST Version]
  13. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 26107113 [NOT CITED] [LATEST Version]
  14. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 21678379 [NOT CITED] [OLD Version]
  15. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. PMID: 21412895 [NOT CITED] [LATEST Version]
4515 Q1128996 dysplasia Dysplasia Start 2-High

Hematology-oncology
  1. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 16855973 [NOT CITED] [LATEST Version]
  2. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 11405998 [NOT CITED] [OLD Version]
  3. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 10796271 [NOT CITED] [OLD Version]
  4. Air versus oxygen for resuscitation of infants at birth. PMID: 15846632 [NOT CITED] [LATEST Version]
  5. Air versus oxygen for resuscitation of infants at birth. PMID: 15266466 [NOT CITED] [OLD Version]
  6. Albumin infusion for low serum albumin in preterm newborn infants. PMID: 15266522 [NOT CITED] [LATEST Version]
  7. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. PMID: 26630252 [NOT CITED] [LATEST Version]
  8. Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome. PMID: 25361381 [NOT CITED] [LATEST Version]
  9. Animal derived surfactant extract for treatment of respiratory distress syndrome. PMID: 19370695 [NOT CITED] [LATEST Version]
  10. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26301526 [NOT CITED] [LATEST Version]
  11. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26009996 [NOT CITED] [OLD Version]
  12. Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants. PMID: 26998583 [NOT CITED] [LATEST Version]
  13. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. PMID: 11687053 [NOT CITED] [LATEST Version]
  14. Continuous distending pressure for respiratory distress in preterm infants. PMID: 26141572 [NOT CITED] [LATEST Version]
  15. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. PMID: 18254092 [NOT CITED] [LATEST Version]
  16. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. PMID: 17054219 [NOT CITED] [LATEST Version]
  17. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. PMID: 18843729 [NOT CITED] [LATEST Version]
  18. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 11869608 [NOT CITED] [LATEST Version]
  19. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 10908511 [NOT CITED] [OLD Version]
  20. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 10796274 [NOT CITED] [OLD Version]
  21. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 29063585 [NOT CITED] [LATEST Version]
  22. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856062 [NOT CITED] [LATEST Version]
  23. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. PMID: 12076469 [NOT CITED] [LATEST Version]
  24. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 15266470 [NOT CITED] [LATEST Version]
  25. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 17943779 [NOT CITED] [LATEST Version]
  26. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076463 [NOT CITED] [LATEST Version]
  27. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 23152207 [NOT CITED] [LATEST Version]
  28. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 10796266 [NOT CITED] [OLD Version]
  29. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI. PMID: 26943923 [NOT CITED] [LATEST Version]
  30. Flow-cycled versus time-cycled synchronized ventilation for neonates. PMID: 20614468 [NOT CITED] [LATEST Version]
  31. Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants. PMID: 21735414 [NOT CITED] [LATEST Version]
  32. Fluid restriction for treatment of preterm infants with chronic lung disease. PMID: 28176308 [NOT CITED] [LATEST Version]
  33. Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns. PMID: 26945780 [NOT CITED] [LATEST Version]
  34. Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes. PMID: 26880256 [NOT CITED] [LATEST Version]
  35. Heparin for the prevention of intraventricular haemorrhage in preterm infants. PMID: 27148674 [NOT CITED] [LATEST Version]
  36. High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants. PMID: 28898404 [NOT CITED] [LATEST Version]
  37. Imaging modalities for characterising focal pancreatic lesions. PMID: 28415140 [NOT CITED] [LATEST Version]
  38. Immunoglobulin for preventing respiratory syncytial virus infection. PMID: 10796658 [NOT CITED] [LATEST Version]
  39. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease. PMID: 16856077 [NOT CITED] [LATEST Version]
  40. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 28045472 [NOT CITED] [LATEST Version]
  41. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 21154346 [NOT CITED] [OLD Version]
  42. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 17636641 [NOT CITED] [OLD Version]
  43. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 16437426 [NOT CITED] [OLD Version]
  44. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11687084 [NOT CITED] [OLD Version]
  45. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11686963 [NOT CITED] [OLD Version]
  46. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 10796215 [NOT CITED] [OLD Version]
  47. Inhaled steroids for neonatal chronic lung disease. PMID: 10908553 [NOT CITED] [LATEST Version]
  48. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. PMID: 29041034 [NOT CITED] [LATEST Version]
  49. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. PMID: 29035425 [NOT CITED] [LATEST Version]
  50. Inositol for respiratory distress syndrome in preterm infants. PMID: 22419275 [NOT CITED] [LATEST Version]
  51. Inositol for respiratory distress syndrome in preterm infants. PMID: 14583919 [NOT CITED] [OLD Version]
  52. Inositol for respiratory distress syndrome in preterm infants. PMID: 11034685 [NOT CITED] [OLD Version]
  53. Inositol for respiratory distress syndrome in preterm infants. PMID: 10796200 [NOT CITED] [OLD Version]
  54. Inositol in preterm infants at risk for or having respiratory distress syndrome. PMID: 31283839 [NOT CITED] [LATEST Version]
  55. Inositol in preterm infants at risk for or having respiratory distress syndrome. PMID: 25927089 [NOT CITED] [OLD Version]
  56. Interventions for treating oral leukoplakia. PMID: 17054142 [NOT CITED] [LATEST Version]
  57. Interventions for treating oral leukoplakia. PMID: 15266454 [NOT CITED] [OLD Version]
  58. Interventions for treating oral leukoplakia. PMID: 11687126 [NOT CITED] [OLD Version]
  59. Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants. PMID: 29431872 [NOT CITED] [LATEST Version]
  60. Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. PMID: 20091659 [NOT CITED] [LATEST Version]
  61. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. PMID: 23821390 [NOT CITED] [LATEST Version]
  62. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 14973955 [NOT CITED] [LATEST Version]
  63. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 11405962 [NOT CITED] [OLD Version]
  64. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 10796199 [NOT CITED] [OLD Version]
  65. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. PMID: 11034718 [NOT CITED] [LATEST Version]
  66. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. PMID: 10796264 [NOT CITED] [OLD Version]
  67. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. PMID: 21735428 [NOT CITED] [LATEST Version]
  68. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 29063594 [NOT CITED] [LATEST Version]
  69. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. PMID: 28836266 [NOT CITED] [LATEST Version]
  70. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. PMID: 22513906 [NOT CITED] [OLD Version]
  71. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856064 [NOT CITED] [LATEST Version]
  72. Lipid emulsions for parenterally fed preterm infants. PMID: 31158919 [NOT CITED] [LATEST Version]
  73. Long versus short inspiratory times in neonates receiving mechanical ventilation. PMID: 15495117 [NOT CITED] [LATEST Version]
  74. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. PMID: 25464111 [NOT CITED] [LATEST Version]
  75. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. PMID: 29125893 [NOT CITED] [LATEST Version]
  76. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. PMID: 19160177 [NOT CITED] [LATEST Version]
  77. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. PMID: 11405951 [NOT CITED] [LATEST Version]
  78. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. PMID: 23076945 [NOT CITED] [LATEST Version]
  79. Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support. PMID: 29077984 [NOT CITED] [LATEST Version]
  80. Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants. PMID: 25418278 [NOT CITED] [LATEST Version]
  81. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. PMID: 21412918 [NOT CITED] [LATEST Version]
  82. Positive end expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 22258957 [NOT CITED] [LATEST Version]
  83. Positive end-expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 30820939 [NOT CITED] [LATEST Version]
  84. Prophylactic methylxanthines for endotracheal extubation in preterm infants. PMID: 21154342 [NOT CITED] [LATEST Version]
  85. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. PMID: 27315509 [NOT CITED] [LATEST Version]
  86. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. PMID: 10796380 [NOT CITED] [LATEST Version]
  87. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 20091513 [NOT CITED] [LATEST Version]
  88. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. PMID: 18254095 [NOT CITED] [LATEST Version]
  89. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796410 [NOT CITED] [LATEST Version]
  90. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796379 [NOT CITED] [LATEST Version]
  91. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. PMID: 11405966 [NOT CITED] [LATEST Version]
  92. Prostaglandins before caesarean section for preventing neonatal respiratory distress. PMID: 24218013 [NOT CITED] [LATEST Version]
  93. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 25473815 [NOT CITED] [LATEST Version]
  94. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 18253981 [NOT CITED] [OLD Version]
  95. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 11686962 [NOT CITED] [OLD Version]
  96. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 10796373 [NOT CITED] [OLD Version]
  97. Screening programmes for developmental dysplasia of the hip in newborn infants. PMID: 21901691 [NOT CITED] [LATEST Version]
  98. Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants. PMID: 25633155 [NOT CITED] [LATEST Version]
  99. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. PMID: 16625534 [NOT CITED] [LATEST Version]
  100. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. PMID: 15106148 [NOT CITED] [OLD Version]
  101. Strategies for detecting colon cancer in patients with inflammatory bowel disease. PMID: 28922695 [NOT CITED] [LATEST Version]
  102. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. PMID: 11279743 [NOT CITED] [LATEST Version]
  103. Surgery for epilepsy. PMID: 31237346 [NOT CITED] [LATEST Version]
  104. Surgery for epilepsy. PMID: 26130264 [NOT CITED] [OLD Version]
  105. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. PMID: 20464752 [NOT CITED] [LATEST Version]
  106. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. PMID: 19370683 [NOT CITED] [OLD Version]
  107. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. PMID: 23152243 [NOT CITED] [LATEST Version]
  108. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. PMID: 24062262 [NOT CITED] [LATEST Version]
  109. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. PMID: 28707404 [NOT CITED] [LATEST Version]
  110. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27581993 [NOT CITED] [LATEST Version]
  111. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27539719 [NOT CITED] [OLD Version]
  112. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 18253979 [NOT CITED] [OLD Version]
  113. Synthetic surfactant for respiratory distress syndrome in preterm infants. PMID: 10796417 [NOT CITED] [LATEST Version]
  114. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 28141913 [NOT CITED] [LATEST Version]
  115. Thrombopoietin mimetics for patients with myelodysplastic syndromes. PMID: 28962071 [NOT CITED] [LATEST Version]
  116. Treatment for Barrett's oesophagus. PMID: 20091557 [NOT CITED] [LATEST Version]
  117. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. PMID: 12519545 [NOT CITED] [LATEST Version]
  118. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. PMID: 10796372 [NOT CITED] [OLD Version]
  119. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. PMID: 17943744 [NOT CITED] [LATEST Version]
  120. Volume-targeted versus pressure-limited ventilation in neonates. PMID: 29039883 [NOT CITED] [LATEST Version]
  121. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 21069677 [NOT CITED] [LATEST Version]
  122. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 16034906 [NOT CITED] [OLD Version]
2318 Q729735 chronic myeloid leukemia Chronic myelogenous leukemia B 2-High

Hematology-oncology

 No matching publication found!
4467 Q1088156 chronic lymphocytic leukemia Chronic lymphocytic leukemia C 2-High

Hematology-oncology

 No matching publication found!
64 Q172341 ovarian cancer Ovarian cancer B 2-High

Hematology-oncology

Pathology
  1. Acupuncture for cancer pain in adults. PMID: 26468973 [NOT CITED] [LATEST Version]
  2. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 26676202 [NOT CITED] [LATEST Version]
  3. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 22419298 [NOT CITED] [OLD Version]
  4. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 19588360 [NOT CITED] [OLD Version]
  5. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 19160239 [NOT CITED] [OLD Version]
  6. Angiogenesis inhibitors for the treatment of ovarian cancer. PMID: 21901715 [NOT CITED] [LATEST Version]
  7. Antigen-specific active immunotherapy for ovarian cancer. PMID: 30199097 [CITED] [LATEST Version]
  8. Antigen-specific active immunotherapy for ovarian cancer. PMID: 25229990 [NOT CITED] [OLD Version]
  9. Antigen-specific active immunotherapy for ovarian cancer. PMID: 20091627 [NOT CITED] [OLD Version]
  10. Centralisation of services for gynaecological cancer. PMID: 22419327 [NOT CITED] [LATEST Version]
  11. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group. PMID: 10796788 [NOT CITED] [LATEST Version]
  12. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease. PMID: 21412906 [NOT CITED] [LATEST Version]
  13. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. PMID: 22895947 [NOT CITED] [LATEST Version]
  14. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. PMID: 17943850 [NOT CITED] [OLD Version]
  15. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. PMID: 10796477 [NOT CITED] [LATEST Version]
  16. Clomiphene citrate for unexplained subfertility in women. PMID: 20091498 [NOT CITED] [LATEST Version]
  17. Clomiphene citrate for unexplained subfertility in women. PMID: 10908459 [NOT CITED] [OLD Version]
  18. Clomiphene citrate for unexplained subfertility in women. PMID: 10796478 [NOT CITED] [OLD Version]
  19. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. PMID: 20556785 [NOT CITED] [LATEST Version]
  20. DNA-repair pathway inhibitors for the treatment of ovarian cancer. PMID: 20556786 [NOT CITED] [LATEST Version]
  21. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. PMID: 26801659 [NOT CITED] [LATEST Version]
  22. Epidermal growth factor receptor blockers for the treatment of ovarian cancer. PMID: 30321910 [NOT CITED] [LATEST Version]
  23. Epidermal growth factor receptor blockers for the treatment of ovarian cancer. PMID: 21975775 [NOT CITED] [OLD Version]
  24. Epidermal growth factor receptor blockers for the treatment of ovarian cancer. PMID: 25408621 [NOT CITED] [OLD Version]
  25. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment. PMID: 25198378 [NOT CITED] [LATEST Version]
  26. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment. PMID: 21678351 [NOT CITED] [OLD Version]
  27. Exenterative surgery for recurrent gynaecological malignancies. PMID: 24497188 [NOT CITED] [LATEST Version]
  28. Green tea (Camellia sinensis) for the prevention of cancer. PMID: 19588362 [NOT CITED] [LATEST Version]
  29. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women. PMID: 25101365 [NOT CITED] [LATEST Version]
  30. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women. PMID: 18646133 [NOT CITED] [OLD Version]
  31. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. PMID: 31456223 [NOT CITED] [LATEST Version]
  32. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer. PMID: 23740789 [NOT CITED] [LATEST Version]
  33. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 26747297 [NOT CITED] [LATEST Version]
  34. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 23633332 [NOT CITED] [OLD Version]
  35. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 20927744 [NOT CITED] [OLD Version]
  36. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 19370622 [NOT CITED] [OLD Version]
  37. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 19160263 [NOT CITED] [OLD Version]
  38. Interval debulking surgery for advanced epithelial ovarian cancer. PMID: 18843699 [NOT CITED] [OLD Version]
  39. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. PMID: 26930463 [NOT CITED] [LATEST Version]
  40. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. PMID: 26755441 [NOT CITED] [LATEST Version]
  41. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. PMID: 22071822 [NOT CITED] [OLD Version]
  42. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. PMID: 16437527 [NOT CITED] [OLD Version]
  43. Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer. PMID: 24563459 [NOT CITED] [LATEST Version]
  44. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. PMID: 30907434 [NOT CITED] [LATEST Version]
  45. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. PMID: 27737492 [CITED] [LATEST Version]
  46. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. PMID: 23450560 [NOT CITED] [OLD Version]
  47. Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer. PMID: 18843688 [NOT CITED] [OLD Version]
  48. Long term hormone therapy for perimenopausal and postmenopausal women. PMID: 16034922 [NOT CITED] [LATEST Version]
  49. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer. PMID: 27356090 [NOT CITED] [LATEST Version]
  50. Maintenance chemotherapy for ovarian cancer. PMID: 23813336 [NOT CITED] [LATEST Version]
  51. Maintenance chemotherapy for ovarian cancer. PMID: 20824860 [NOT CITED] [OLD Version]
  52. Management of drainage for malignant ascites in gynaecological cancer. PMID: 20091648 [NOT CITED] [LATEST Version]
  53. Optimal primary surgical treatment for advanced epithelial ovarian cancer. PMID: 21833960 [NOT CITED] [LATEST Version]
  54. Palliative surgery versus medical management for bowel obstruction in ovarian cancer. PMID: 20614464 [NOT CITED] [LATEST Version]
  55. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer. PMID: 24142521 [NOT CITED] [LATEST Version]
  56. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. PMID: 23835762 [NOT CITED] [LATEST Version]
  57. Perioperative nutrition interventions for women with ovarian cancer. PMID: 24027084 [NOT CITED] [LATEST Version]
  58. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. PMID: 25991068 [NOT CITED] [LATEST Version]
  59. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. PMID: 30298516 [NOT CITED] [LATEST Version]
  60. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. PMID: 31207666 [NOT CITED] [LATEST Version]
  61. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. PMID: 23943232 [NOT CITED] [OLD Version]
  62. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. PMID: 30141832 [NOT CITED] [LATEST Version]
  63. Robotic assisted surgery for gynaecological cancer. PMID: 22258988 [NOT CITED] [LATEST Version]
  64. Surgical cytoreduction for recurrent epithelial ovarian cancer. PMID: 23450588 [NOT CITED] [LATEST Version]
  65. Tamoxifen for relapse of ovarian cancer. PMID: 20238312 [NOT CITED] [LATEST Version]
  66. Tamoxifen for relapse of ovarian cancer. PMID: 11279703 [NOT CITED] [OLD Version]
  67. Tamoxifen for relapse of ovarian cancer. PMID: 10796734 [NOT CITED] [OLD Version]
  68. Topotecan for ovarian cancer. PMID: 18425923 [NOT CITED] [LATEST Version]
  69. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer. PMID: 21491400 [NOT CITED] [LATEST Version]
161 Q209369 Hodgkin's lymphoma Hodgkin's lymphoma B 2-High

Hematology-oncology

Pathology
  1. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. PMID: 30827035 [NOT CITED] [LATEST Version]
  2. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. PMID: 17943799 [NOT CITED] [LATEST Version]
  3. Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk. PMID: 16235316 [NOT CITED] [LATEST Version]
  4. Interferon-alpha for maintenance of follicular lymphoma. PMID: 20091564 [NOT CITED] [LATEST Version]
  5. Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma. PMID: 19588373 [NOT CITED] [LATEST Version]
  6. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). PMID: 30001476 [NOT CITED] [LATEST Version]
  7. Yoga in addition to standard care for patients with haematological malignancies. PMID: 24919720 [NOT CITED] [LATEST Version]
157 Q208414 lymphoma Lymphoma B 2-High

Hematology-oncology
  1. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma. PMID: 26484982 [NOT CITED] [LATEST Version]
  2. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. PMID: 30827035 [NOT CITED] [LATEST Version]
  3. Adverse effects of biologics: a network meta-analysis and Cochrane overview. PMID: 21328309 [NOT CITED] [LATEST Version]
  4. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 30702150 [NOT CITED] [LATEST Version]
  5. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 25386666 [NOT CITED] [OLD Version]
  6. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. PMID: 23986525 [NOT CITED] [LATEST Version]
  7. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. PMID: 22258991 [NOT CITED] [OLD Version]
  8. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. PMID: 27548292 [NOT CITED] [LATEST Version]
  9. Anthracycline-containing regimens for treatment of follicular lymphoma in adults. PMID: 23832787 [NOT CITED] [LATEST Version]
  10. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. PMID: 22258955 [NOT CITED] [LATEST Version]
  11. Antibody therapies for lymphoma in children. PMID: 26784573 [NOT CITED] [LATEST Version]
  12. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. PMID: 22972131 [NOT CITED] [LATEST Version]
  13. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma. PMID: 28447341 [NOT CITED] [LATEST Version]
  14. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. PMID: 21328291 [NOT CITED] [LATEST Version]
  15. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. PMID: 17943799 [NOT CITED] [LATEST Version]
  16. Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk. PMID: 16235316 [NOT CITED] [LATEST Version]
  17. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 21833963 [NOT CITED] [LATEST Version]
  18. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 28541603 [NOT CITED] [LATEST Version]
  19. Exercise interventions on health-related quality of life for cancer survivors. PMID: 22895961 [NOT CITED] [LATEST Version]
  20. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma. PMID: 12519588 [NOT CITED] [LATEST Version]
  21. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 18843642 [NOT CITED] [LATEST Version]
  22. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 14974009 [NOT CITED] [OLD Version]
  23. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 15266474 [NOT CITED] [OLD Version]
  24. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma. PMID: 23784872 [NOT CITED] [LATEST Version]
  25. High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults. PMID: 18254036 [NOT CITED] [LATEST Version]
  26. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. PMID: 22258971 [NOT CITED] [LATEST Version]
  27. Interferon-alpha for maintenance of follicular lymphoma. PMID: 20091564 [NOT CITED] [LATEST Version]
  28. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. PMID: 31525824 [NOT CITED] [LATEST Version]
  29. Interventions for mycosis fungoides. PMID: 22972128 [NOT CITED] [LATEST Version]
  30. Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma. PMID: 19588373 [NOT CITED] [LATEST Version]
  31. Interventions for treating AIDS-associated Hodgkin s lymphoma in treatment-naive adults. PMID: 17443616 [NOT CITED] [LATEST Version]
  32. Meditation for adults with haematological malignancies. PMID: 26840029 [NOT CITED] [LATEST Version]
  33. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). PMID: 30001476 [NOT CITED] [LATEST Version]
  34. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis. PMID: 28901021 [NOT CITED] [LATEST Version]
  35. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. PMID: 25572491 [NOT CITED] [LATEST Version]
  36. Rituximab as maintenance therapy for patients with follicular lymphoma. PMID: 19370640 [NOT CITED] [LATEST Version]
  37. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). PMID: 23152274 [NOT CITED] [LATEST Version]
  38. The role of additional radiotherapy for primary central nervous system lymphoma. PMID: 24931518 [NOT CITED] [LATEST Version]
  39. Therapeutic interventions for Burkitt lymphoma in children. PMID: 21735399 [NOT CITED] [LATEST Version]
  40. Therapeutic interventions for Burkitt's lymphoma in children. PMID: 17054245 [NOT CITED] [LATEST Version]
  41. TNF-alpha inhibitors for ankylosing spondylitis. PMID: 25887212 [NOT CITED] [LATEST Version]
  42. Topical tacrolimus for atopic dermatitis. PMID: 26132597 [NOT CITED] [LATEST Version]
  43. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia. PMID: 29734473 [NOT CITED] [LATEST Version]
  44. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 25188452 [NOT CITED] [LATEST Version]
  45. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 21249679 [NOT CITED] [OLD Version]
  46. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 19160293 [NOT CITED] [OLD Version]
  47. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. PMID: 14974022 [NOT CITED] [LATEST Version]
  48. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. PMID: 21412895 [NOT CITED] [LATEST Version]
  49. Yoga in addition to standard care for patients with haematological malignancies. PMID: 24919720 [NOT CITED] [LATEST Version]
242 Q180664 acute lymphocytic leukemia Acute lymphoblastic leukemia C 2-High

Hematology-oncology
  1. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. PMID: 21975786 [NOT CITED] [LATEST Version]
  2. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 25269391 [NOT CITED] [LATEST Version]
264 Q181876 metastasis Metastasis B 2-High

Hematology-oncology
  1. Adjuvant chemotherapy for endometrial cancer after hysterectomy. PMID: 21975736 [NOT CITED] [LATEST Version]
  2. Adjuvant platinum-based chemotherapy for early stage cervical cancer. PMID: 19588370 [NOT CITED] [LATEST Version]
  3. Angiogenesis-inhibitors for metastatic thyroid cancer. PMID: 20238360 [NOT CITED] [LATEST Version]
  4. Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation. PMID: 31016728 [NOT CITED] [LATEST Version]
  5. Axillary treatment for operable primary breast cancer. PMID: 28052186 [NOT CITED] [LATEST Version]
  6. Calcitonin for metastatic bone pain. PMID: 12917954 [NOT CITED] [LATEST Version]
  7. Chemotherapy for advanced gastric cancer. PMID: 20238327 [NOT CITED] [LATEST Version]
  8. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. PMID: 25400254 [NOT CITED] [LATEST Version]
  9. Corticosteroids for the management of cancer-related pain in adults. PMID: 25908299 [NOT CITED] [LATEST Version]
  10. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. PMID: 11034766 [NOT CITED] [LATEST Version]
  11. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. PMID: 30550641 [NOT CITED] [LATEST Version]
  12. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 25300170 [NOT CITED] [LATEST Version]
  13. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 20614461 [NOT CITED] [OLD Version]
  14. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. PMID: 29637538 [NOT CITED] [LATEST Version]
  15. Hypofractionation for clinically localized prostate cancer. PMID: 31476800 [NOT CITED] [LATEST Version]
  16. Image guided surgery for the resection of brain tumours. PMID: 24474579 [NOT CITED] [LATEST Version]
  17. Interferon alpha for the adjuvant treatment of cutaneous melanoma. PMID: 23775773 [NOT CITED] [LATEST Version]
  18. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. PMID: 15106258 [NOT CITED] [LATEST Version]
  19. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 30888060 [NOT CITED] [LATEST Version]
  20. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. PMID: 25932968 [NOT CITED] [OLD Version]
  21. Partial breast irradiation for early breast cancer. PMID: 27425375 [NOT CITED] [LATEST Version]
  22. Partial breast irradiation for early breast cancer. PMID: 24938937 [NOT CITED] [OLD Version]
  23. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 26233609 [NOT CITED] [LATEST Version]
  24. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 18843733 [NOT CITED] [OLD Version]
  25. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. PMID: 23450565 [NOT CITED] [LATEST Version]
  26. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. PMID: 19160264 [NOT CITED] [OLD Version]
  27. Radioisotopes for metastatic bone pain. PMID: 21735393 [NOT CITED] [LATEST Version]
  28. Radioisotopes for metastatic bone pain. PMID: 14583970 [NOT CITED] [OLD Version]
  29. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. PMID: 25989478 [NOT CITED] [LATEST Version]
  30. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation. PMID: 25634649 [NOT CITED] [LATEST Version]
  31. Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. PMID: 28840597 [NOT CITED] [LATEST Version]
  32. Selective internal radiation therapy for liver metastases from colorectal cancer. PMID: 19821394 [NOT CITED] [LATEST Version]
  33. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. PMID: 24970683 [NOT CITED] [LATEST Version]
  34. Sequencing of chemotherapy and radiotherapy for early breast cancer. PMID: 23633328 [NOT CITED] [LATEST Version]
  35. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. PMID: 16437498 [NOT CITED] [LATEST Version]
  36. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis. PMID: 30125049 [NOT CITED] [LATEST Version]
  37. Surgical management for upper urinary tract transitional cell carcinoma. PMID: 21491399 [NOT CITED] [LATEST Version]
  38. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. PMID: 15674905 [NOT CITED] [LATEST Version]
  39. Systemic treatments for metastatic cutaneous melanoma. PMID: 29405038 [NOT CITED] [LATEST Version]
  40. Trastuzumab-containing regimens for metastatic breast cancer. PMID: 24919460 [NOT CITED] [LATEST Version]
  41. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. PMID: 31260100 [NOT CITED] [LATEST Version]
  42. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. PMID: 28945270 [NOT CITED] [LATEST Version]
  43. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. PMID: 22972090 [NOT CITED] [OLD Version]
  44. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. PMID: 20556764 [NOT CITED] [OLD Version]
  45. Whole brain radiotherapy for the treatment of multiple brain metastases. PMID: 16856022 [NOT CITED] [LATEST Version]
  46. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. PMID: 22513917 [NOT CITED] [LATEST Version]
188 Q212961 pancreatic cancer Pancreatic cancer FA 2-High

Hematology-oncology
  1. Acupuncture for cancer pain in adults. PMID: 26468973 [NOT CITED] [LATEST Version]
  2. Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy. PMID: 27689801 [NOT CITED] [LATEST Version]
  3. Celiac plexus block for pancreatic cancer pain in adults. PMID: 21412903 [CITED] [LATEST Version]
  4. Chemotherapy and radiotherapy for advanced pancreatic cancer. PMID: 29557103 [NOT CITED] [LATEST Version]
  5. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. PMID: 16855985 [NOT CITED] [LATEST Version]
  6. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. PMID: 27631326 [NOT CITED] [LATEST Version]
  7. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. PMID: 27383694 [CITED] [LATEST Version]
  8. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. PMID: 24272022 [NOT CITED] [OLD Version]
  9. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis. PMID: 26837472 [NOT CITED] [LATEST Version]
  10. Green tea (Camellia sinensis) for the prevention of cancer. PMID: 19588362 [NOT CITED] [LATEST Version]
  11. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. PMID: 30246878 [NOT CITED] [LATEST Version]
  12. Laparoscopic versus open distal pancreatectomy for pancreatic cancer. PMID: 27043078 [NOT CITED] [LATEST Version]
  13. Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 18425935 [NOT CITED] [LATEST Version]
  14. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 26905229 [NOT CITED] [LATEST Version]
  15. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 25387229 [NOT CITED] [OLD Version]
  16. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 21563148 [NOT CITED] [OLD Version]
  17. Resection versus other treatments for locally advanced pancreatic cancer. PMID: 24578248 [CITED] [LATEST Version]
  18. Supportive care for patients with gastrointestinal cancer. PMID: 15266485 [NOT CITED] [LATEST Version]
4576 Q1143025 oral cavity cancer Oral cancer B 2-High

Hematology-oncology
  1. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. PMID: 24258195 [NOT CITED] [LATEST Version]
  2. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. PMID: 30582609 [NOT CITED] [LATEST Version]
  3. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. PMID: 21901703 [NOT CITED] [OLD Version]
  4. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. PMID: 21491393 [NOT CITED] [LATEST Version]
  5. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. PMID: 20824847 [NOT CITED] [OLD Version]
2958 Q1757427 pancytopenia Pancytopenia Start 3-Mid

Hematology-oncology
  1. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. PMID: 23881658 [NOT CITED] [LATEST Version]
2904 Q7168876 peritoneal mesothelioma Peritoneal mesothelioma Start 3-Mid

Hematology-oncology

 No matching publication found!
2896 Q4677917 Acute biphenotypic leukaemia Acute biphenotypic leukaemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
2931 Q7202249 platelet storage pool deficiency Platelet storage pool deficiency C 3-Mid

Hematology-oncology

 No matching publication found!
2895 Q4677911 Acute basophilic leukemia Acute basophilic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
2879 Q4651856 AIDS-related lymphoma AIDS-related lymphoma Start 3-Mid

Hematology-oncology

 No matching publication found!
3083 Q4818889 Atypical ductal hyperplasia Atypical ductal hyperplasia C 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
3101 Q4833719 B-cell lymphoma B-cell lymphoma Start 3-Mid

Hematology-oncology
  1. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. PMID: 25572491 [NOT CITED] [LATEST Version]
  2. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia. PMID: 29734473 [NOT CITED] [LATEST Version]
3067 Q1898141 rhabdomyosarcoma Rhabdomyosarcoma C 3-Mid

Hematology-oncology

Pathology
  1. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas. PMID: 23925699 [NOT CITED] [LATEST Version]
  2. Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas. PMID: 21328307 [NOT CITED] [LATEST Version]
  3. Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas. PMID: 28407197 [NOT CITED] [LATEST Version]
  4. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. PMID: 21154373 [NOT CITED] [LATEST Version]
  5. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 25188452 [NOT CITED] [LATEST Version]
  6. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 21249679 [NOT CITED] [OLD Version]
  7. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 19160293 [NOT CITED] [OLD Version]
2984 Q1778287 Waldenström's macroglobulinemia Waldenström's macroglobulinemia C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
3012 Q7132981 Papillary adenocarcinoma Papillary adenocarcinoma Stub 3-Mid

Hematology-oncology

Pulmonology

 No matching publication found!
2859 Q1783924 head and neck cancer Head and neck cancer B 3-Mid

Hematology-oncology
  1. Dental extractions prior to radiotherapy to the jaws for reducing post-radiotherapy dental complications. PMID: 23450590 [NOT CITED] [LATEST Version]
  2. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. PMID: 23440820 [NOT CITED] [LATEST Version]
  3. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. PMID: 20238358 [NOT CITED] [OLD Version]
  4. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. PMID: 19588382 [NOT CITED] [LATEST Version]
  5. Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer. PMID: 22513964 [NOT CITED] [LATEST Version]
  6. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. PMID: 29637538 [NOT CITED] [LATEST Version]
  7. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. PMID: 22513926 [NOT CITED] [OLD Version]
  8. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. PMID: 16235387 [NOT CITED] [OLD Version]
  9. Hyperfractionated or accelerated radiotherapy for head and neck cancer. PMID: 21154350 [NOT CITED] [LATEST Version]
  10. Immunonutrition for patients undergoing surgery for head and neck cancer. PMID: 30160300 [NOT CITED] [LATEST Version]
  11. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. PMID: 21491393 [NOT CITED] [LATEST Version]
  12. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. PMID: 20824847 [NOT CITED] [OLD Version]
  13. Mistletoe therapy in oncology. PMID: 18425885 [NOT CITED] [LATEST Version]
  14. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). PMID: 10796567 [NOT CITED] [LATEST Version]
  15. Psychosocial interventions for patients with head and neck cancer. PMID: 23857592 [NOT CITED] [LATEST Version]
  16. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers. PMID: 27562477 [NOT CITED] [LATEST Version]
3064 Q1891209 mycosis fungoides Mycosis fungoides C 3-Mid

Dermatology

Hematology-oncology

Pathology
  1. Interventions for mycosis fungoides. PMID: 22972128 [CITED] [LATEST Version]
3066 Q1898104 myeloproliferative disorders Myeloproliferative neoplasm C 3-Mid

Hematology-oncology
  1. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. PMID: 18425953 [NOT CITED] [LATEST Version]
  2. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 16856046 [NOT CITED] [LATEST Version]
3112 Q7542594 Small-blue-round-cell tumor Small-blue-round-cell tumor Start 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
53 Q379054 Adult T-cell leukemia/lymphoma Adult T-cell leukemia/lymphoma Start 3-Mid

Hematology-oncology

 No matching publication found!
2550 Q6708277 lymphoid leukemia Lymphoid leukemia Start 3-Mid

Hematology-oncology

 No matching publication found!
2773 Q4677943 acute myelomonocytic leukemia Acute myelomonocytic leukemia Start 3-Mid

Hematology-oncology

 No matching publication found!
2167 Q1598365 heparin-induced thrombocytopenia Heparin-induced thrombocytopenia GA 3-Mid

Hematology-oncology
  1. Heparin for prolonging peripheral intravenous catheter use in neonates. PMID: 16235300 [NOT CITED] [LATEST Version]
  2. Heparin for prolonging peripheral intravenous catheter use in neonates. PMID: 12519576 [NOT CITED] [OLD Version]
  3. Heparin for the treatment of thrombosis in neonates. PMID: 27820879 [NOT CITED] [LATEST Version]
  4. Heparin versus normal saline for patency of arterial lines. PMID: 24825673 [NOT CITED] [LATEST Version]
  5. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. PMID: 24771319 [NOT CITED] [LATEST Version]
  6. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. PMID: 18843725 [NOT CITED] [OLD Version]
  7. Pentasaccharides for the prevention of venous thromboembolism. PMID: 27797404 [NOT CITED] [LATEST Version]
  8. Pentasaccharides for the treatment of deep vein thrombosis. PMID: 29199766 [NOT CITED] [LATEST Version]
  9. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. PMID: 24026801 [NOT CITED] [LATEST Version]
  10. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 22972111 [NOT CITED] [LATEST Version]
  11. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 28431186 [NOT CITED] [LATEST Version]
2180 Q6132707 thrombocytopenic purpura Thrombocytopenic purpura Stub 3-Mid

Dermatology

Hematology-oncology
  1. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. PMID: 19160220 [NOT CITED] [LATEST Version]
  2. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. PMID: 19821437 [NOT CITED] [LATEST Version]
  3. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. PMID: 10796426 [NOT CITED] [LATEST Version]
  4. Ticlopidine versus oral anticoagulation for coronary stenting. PMID: 11687144 [NOT CITED] [LATEST Version]
  5. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. PMID: 21735426 [NOT CITED] [LATEST Version]
  6. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. PMID: 25348587 [NOT CITED] [LATEST Version]
  7. Vaccines for measles, mumps and rubella in children. PMID: 22336803 [NOT CITED] [LATEST Version]
  8. Vaccines for measles, mumps and rubella in children. PMID: 16235361 [NOT CITED] [OLD Version]
2229 Q1614115 hypervolemia Hypervolemia Start 3-Mid

Hematology-oncology

 No matching publication found!
2246 Q3832900 splenic marginal zone lymphoma Splenic marginal zone lymphoma Start 3-Mid

Hematology-oncology

 No matching publication found!
2340 Q4118092 macroglobulinemia Macroglobulinemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
2370 Q6901506 monocytic leukemia Monocytic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
2398 Q17152512 T-cell prolymphocytic leukemia T-cell prolymphocytic leukemia C 3-Mid

Hematology-oncology

 No matching publication found!
2430 Q1693598 nasopharynx carcinoma Nasopharynx cancer Start 3-Mid

Hematology-oncology

 No matching publication found!
2791 Q4692280 natural killer cell leukemia Aggressive NK-cell leukemia C 3-Mid

Hematology-oncology

 No matching publication found!
2519 Q709360 von Willebrand's disease Von Willebrand disease B 3-Mid

Hematology-oncology

Medical genetics
  1. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. PMID: 31002742 [NOT CITED] [LATEST Version]
  2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. PMID: 26704192 [NOT CITED] [OLD Version]
2603 Q1671685 invasive mammary ductal carcinoma Invasive carcinoma of no special type C 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
2616 Q4165484 Lymphoproliferative disorders Lymphoproliferative disorders Start 3-Mid

Hematology-oncology
  1. Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation. PMID: 18843719 [NOT CITED] [LATEST Version]
2623 Q6784873 Mast cell leukemia Mast cell leukemia C 3-Mid

Hematology-oncology

 No matching publication found!
2689 Q1755487 neonatal jaundice Neonatal jaundice C 3-Mid

Hematology-oncology
  1. Active versus expectant management for women in the third stage of labour. PMID: 30754073 [NOT CITED] [LATEST Version]
  2. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. PMID: 17443599 [NOT CITED] [LATEST Version]
  3. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. PMID: 26334436 [NOT CITED] [LATEST Version]
  4. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. PMID: 23450526 [NOT CITED] [OLD Version]
  5. Anti-D administration in pregnancy for preventing rhesus alloimmunisation. PMID: 10796088 [NOT CITED] [OLD Version]
  6. Calcium channel blockers for inhibiting preterm labour and birth. PMID: 24901312 [NOT CITED] [LATEST Version]
  7. Calcium channel blockers for inhibiting preterm labour. PMID: 12535434 [NOT CITED] [LATEST Version]
  8. Calcium channel blockers for inhibiting preterm labour. PMID: 12076443 [NOT CITED] [OLD Version]
  9. Early intravenous nutrition for the prevention of neonatal jaundice. PMID: 12917992 [NOT CITED] [LATEST Version]
  10. Fibreoptic phototherapy for neonatal jaundice. PMID: 11279748 [NOT CITED] [LATEST Version]
  11. Home- versus hospital-based phototherapy for the treatment of non-haemolytic jaundice in infants at more than 37 weeks' gestation. PMID: 24913724 [NOT CITED] [LATEST Version]
  12. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. PMID: 26059051 [NOT CITED] [LATEST Version]
  13. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. PMID: 30246877 [NOT CITED] [LATEST Version]
2751 Q18553449 marginal zone B-cell lymphoma Marginal zone B-cell lymphoma Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
2766 Q1807522 vaginal cancer Vaginal cancer Start 3-Mid

Hematology-oncology

 No matching publication found!
2771 Q4677938 acute monocytic leukemia Acute monocytic leukemia Start 3-Mid

Hematology-oncology

 No matching publication found!
2772 Q4677939 Acute myeloid dendritic cell leukemia BPDCN B 3-Mid

Hematology-oncology

 No matching publication found!
3161 Q1786953 seminoma Seminoma B 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
3182 Q4677933 Acute megakaryoblastic leukemia Acute megakaryoblastic leukemia C 3-Mid

Hematology-oncology

 No matching publication found!
3564 Q7667895 T-cell leukemia T-cell leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
3196 Q7239586 Precursor B-cell lymphoblastic leukemia Precursor B-cell lymphoblastic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
4067 Q2292945 papillary thyroid cancer Papillary thyroid cancer Start 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
4105 Q53660452 primary mediastinal B-cell lymphoma Primary mediastinal B-cell lymphoma Start 3-Mid

Hematology-oncology

 No matching publication found!
4190 Q4763254 extranodal NK/T-cell lymphoma, nasal type Extranodal NK/T-cell lymphoma, nasal type C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
4191 Q4763257 Angioimmunoblastic T-cell lymphoma Angioimmunoblastic T-cell lymphoma C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
4216 Q933716 polycythemia Polycythemia C 3-Mid

Hematology-oncology
  1. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. PMID: 20091569 [NOT CITED] [LATEST Version]
4228 Q1016605 Burkitt lymphoma Burkitt's lymphoma C 3-Mid

Hematology-oncology
  1. Therapeutic interventions for Burkitt lymphoma in children. PMID: 21735399 [NOT CITED] [LATEST Version]
4235 Q1024546 Cancer of unknown primary origin Cancer of unknown primary origin C 3-Mid

Hematology-oncology

 No matching publication found!
4319 Q1035319 Henoch-Schoenlein purpura Henoch–Schönlein purpura GA 3-Mid

Dermatology

Hematology-oncology
  1. Fasting for haemostasis in children with gastrointestinal bleeding. PMID: 27197069 [NOT CITED] [LATEST Version]
  2. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP). PMID: 26258874 [CITED] [LATEST Version]
  3. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP). PMID: 19588365 [NOT CITED] [OLD Version]
4320 Q1035645 in situ carcinoma Carcinoma in situ Start 3-Mid

Hematology-oncology
  1. Risk-reducing medications for primary breast cancer: a network meta-analysis. PMID: 31032883 [NOT CITED] [LATEST Version]
4355 Q2562598 hemophilia B Haemophilia B C 3-Mid

Hematology-oncology

Medical genetics
  1. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 21901684 [NOT CITED] [LATEST Version]
  2. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 16625581 [NOT CITED] [OLD Version]
  3. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 15846666 [NOT CITED] [OLD Version]
4394 Q2578247 juvenile myelomonocytic leukemia Juvenile myelomonocytic leukemia C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
4430 Q1076087 chondrosarcoma Chondrosarcoma C 3-Mid

Hematology-oncology
  1. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones. PMID: 30845364 [NOT CITED] [LATEST Version]
4434 Q2619315 synovial sarcoma Synovial sarcoma Start 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
4436 Q2626074 diffuse large B-cell lymphoma Diffuse large B-cell lymphoma C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
4466 Q1088072 Chronic myelomonocytic leukemia Chronic myelomonocytic leukemia B 3-Mid

Hematology-oncology

 No matching publication found!
4468 Q1088163 pre-malignant neoplasm Precancerous condition Start 3-Mid

Hematology-oncology
  1. Metformin for endometrial hyperplasia. PMID: 29077194 [NOT CITED] [LATEST Version]
4497 Q1110197 Acute myeloblastic leukemia Acute myeloblastic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
4551 Q1138590 Non-Hodgkin lymphoma Non-Hodgkin lymphoma C 3-Mid

Hematology-oncology

Pathology
  1. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma. PMID: 26484982 [NOT CITED] [LATEST Version]
  2. High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults. PMID: 18254036 [NOT CITED] [LATEST Version]
  3. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). PMID: 23152274 [NOT CITED] [LATEST Version]
  4. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 25188452 [NOT CITED] [LATEST Version]
  5. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 21249679 [NOT CITED] [OLD Version]
  6. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. PMID: 19160293 [NOT CITED] [OLD Version]
4561 Q33525 carcinoma Carcinoma Start 3-Mid

Hematology-oncology
  1. Acupuncture for cancer pain in adults. PMID: 26468973 [NOT CITED] [LATEST Version]
  2. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. PMID: 22419298 [NOT CITED] [LATEST Version]
  3. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. PMID: 25470408 [NOT CITED] [LATEST Version]
  4. Adjuvant chemotherapy for invasive bladder cancer (individual patient data). PMID: 16625650 [NOT CITED] [LATEST Version]
  5. Adjuvant progestagens for endometrial cancer. PMID: 21678331 [NOT CITED] [LATEST Version]
  6. Adjuvant radiotherapy for stage I endometrial cancer. PMID: 22513918 [NOT CITED] [LATEST Version]
  7. Adjuvant radiotherapy for stage I endometrial cancer. PMID: 22419290 [NOT CITED] [OLD Version]
  8. Adjuvant radiotherapy for stage I endometrial cancer. PMID: 17443533 [NOT CITED] [OLD Version]
  9. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. PMID: 12804438 [NOT CITED] [LATEST Version]
  10. Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. PMID: 22972059 [NOT CITED] [LATEST Version]
  11. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C. PMID: 24937404 [NOT CITED] [LATEST Version]
  12. Antibiotic prophylaxis for transrectal prostate biopsy. PMID: 21563156 [NOT CITED] [LATEST Version]
  13. Bicyclol for chronic hepatitis B. PMID: 17054206 [NOT CITED] [LATEST Version]
  14. Bicyclol for chronic hepatitis C. PMID: 17253534 [NOT CITED] [LATEST Version]
  15. Bile acids for viral hepatitis. PMID: 17943781 [NOT CITED] [LATEST Version]
  16. Chemoradiation for advanced primary vulval cancer. PMID: 21491387 [NOT CITED] [LATEST Version]
  17. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. PMID: 28829911 [NOT CITED] [LATEST Version]
  18. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. PMID: 17054200 [NOT CITED] [LATEST Version]
  19. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group. PMID: 10796788 [NOT CITED] [LATEST Version]
  20. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. PMID: 22895938 [NOT CITED] [LATEST Version]
  21. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. PMID: 16235346 [NOT CITED] [OLD Version]
  22. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. PMID: 16034916 [NOT CITED] [OLD Version]
  23. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. PMID: 17054195 [NOT CITED] [LATEST Version]
  24. Chemotherapy for thymic carcinoma and advanced thymoma in adults. PMID: 23970462 [NOT CITED] [LATEST Version]
  25. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. PMID: 16437440 [NOT CITED] [LATEST Version]
  26. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. PMID: 12535428 [NOT CITED] [OLD Version]
  27. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. PMID: 11406033 [NOT CITED] [OLD Version]
  28. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. PMID: 20091593 [NOT CITED] [LATEST Version]
  29. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. PMID: 20238344 [NOT CITED] [LATEST Version]
  30. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. PMID: 30521691 [NOT CITED] [LATEST Version]
  31. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix. PMID: 14974044 [NOT CITED] [LATEST Version]
  32. Covering ileo- or colostomy in anterior resection for rectal carcinoma. PMID: 20464746 [NOT CITED] [LATEST Version]
  33. Cryotherapy for hepatocellular carcinoma. PMID: 19821432 [NOT CITED] [LATEST Version]
  34. Cryotherapy for liver metastases. PMID: 31291464 [NOT CITED] [LATEST Version]
  35. Cryotherapy for liver metastases. PMID: 23740609 [NOT CITED] [OLD Version]
  36. Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? PMID: 15106167 [NOT CITED] [LATEST Version]
  37. Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? PMID: 11869622 [NOT CITED] [OLD Version]
  38. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma. PMID: 24532092 [NOT CITED] [LATEST Version]
  39. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. PMID: 30550641 [NOT CITED] [LATEST Version]
  40. Decision aids for people considering taking part in clinical trials. PMID: 26613337 [NOT CITED] [LATEST Version]
  41. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. PMID: 25914908 [NOT CITED] [LATEST Version]
  42. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. PMID: 26021841 [NOT CITED] [LATEST Version]
  43. Direct-acting antivirals for chronic hepatitis C. PMID: 28922704 [NOT CITED] [LATEST Version]
  44. Direct-acting antivirals for chronic hepatitis C. PMID: 28585310 [NOT CITED] [OLD Version]
  45. Electro-coagulation for liver metastases. PMID: 23728692 [NOT CITED] [LATEST Version]
  46. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults. PMID: 30521689 [NOT CITED] [LATEST Version]
  47. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy. PMID: 31111956 [NOT CITED] [LATEST Version]
  48. Extent of lymph node dissection for adenocarcinoma of the stomach. PMID: 26267122 [NOT CITED] [LATEST Version]
  49. External beam radiotherapy for unresectable hepatocellular carcinoma. PMID: 28267205 [NOT CITED] [LATEST Version]
  50. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. PMID: 21491413 [NOT CITED] [LATEST Version]
  51. Hepatitis B vaccination during pregnancy for preventing infant infection. PMID: 25385500 [NOT CITED] [LATEST Version]
  52. Hepatitis B vaccination during pregnancy for preventing infant infection. PMID: 21412913 [NOT CITED] [OLD Version]
  53. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 25300170 [NOT CITED] [LATEST Version]
  54. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. PMID: 20614461 [NOT CITED] [OLD Version]
  55. High-frequency ultrasound for diagnosing skin cancer in adults. PMID: 30521683 [NOT CITED] [LATEST Version]
  56. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. PMID: 15266429 [NOT CITED] [LATEST Version]
  57. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. PMID: 10796715 [NOT CITED] [OLD Version]
  58. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. PMID: 22895916 [NOT CITED] [LATEST Version]
  59. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. PMID: 19370558 [NOT CITED] [OLD Version]
  60. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. PMID: 29637538 [NOT CITED] [LATEST Version]
  61. Hyperfractionated or accelerated radiotherapy for head and neck cancer. PMID: 21154350 [NOT CITED] [LATEST Version]
  62. Imaging modalities for characterising focal pancreatic lesions. PMID: 28415140 [NOT CITED] [LATEST Version]
  63. Immunotherapy for advanced renal cell cancer. PMID: 15674877 [NOT CITED] [LATEST Version]
  64. Immunotherapy for advanced renal cell cancer. PMID: 10908496 [NOT CITED] [OLD Version]
  65. Immunotherapy for metastatic renal cell carcinoma. PMID: 28504837 [NOT CITED] [LATEST Version]
  66. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. PMID: 23440791 [NOT CITED] [LATEST Version]
  67. Interventions for actinic keratoses. PMID: 23235610 [NOT CITED] [LATEST Version]
  68. Interventions for basal cell carcinoma of the skin. PMID: 17253489 [NOT CITED] [LATEST Version]
  69. Interventions for basal cell carcinoma of the skin. PMID: 12804465 [NOT CITED] [OLD Version]
  70. Interventions for cutaneous Bowen's disease. PMID: 23794286 [NOT CITED] [LATEST Version]
  71. Interventions for dysphagia in oesophageal cancer. PMID: 25354795 [NOT CITED] [LATEST Version]
  72. Interventions for dysphagia in oesophageal cancer. PMID: 19821338 [NOT CITED] [OLD Version]
  73. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer. PMID: 10796735 [NOT CITED] [LATEST Version]
  74. Interventions for hereditary haemochromatosis: an attempted network meta-analysis. PMID: 28273330 [NOT CITED] [LATEST Version]
  75. Interventions for non-metastatic squamous cell carcinoma of the skin. PMID: 20393962 [NOT CITED] [LATEST Version]
  76. Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. PMID: 23450564 [NOT CITED] [LATEST Version]
  77. Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. PMID: 17443606 [NOT CITED] [OLD Version]
  78. Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer. PMID: 21563157 [NOT CITED] [LATEST Version]
  79. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer. PMID: 28268259 [NOT CITED] [LATEST Version]
  80. Intravesical electromotive drug administration for non-muscle invasive bladder cancer. PMID: 28898400 [NOT CITED] [LATEST Version]
  81. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. PMID: 20614442 [NOT CITED] [LATEST Version]
  82. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma. PMID: 22161435 [NOT CITED] [LATEST Version]
  83. Laparoscopic versus open total mesorectal excision for rectal cancer. PMID: 24737031 [NOT CITED] [LATEST Version]
  84. Laparoscopic versus open total mesorectal excision for rectal cancer. PMID: 17054246 [NOT CITED] [OLD Version]
  85. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer. PMID: 27030301 [NOT CITED] [LATEST Version]
  86. Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. PMID: 23737032 [NOT CITED] [LATEST Version]
  87. Long-term results of laparoscopic colorectal cancer resection. PMID: 18425886 [NOT CITED] [LATEST Version]
  88. Lymphadenectomy for the management of endometrial cancer. PMID: 20091639 [NOT CITED] [LATEST Version]
  89. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis. PMID: 28351116 [NOT CITED] [LATEST Version]
  90. Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis. PMID: 28281295 [NOT CITED] [LATEST Version]
  91. Microwave coagulation for liver metastases. PMID: 24122576 [NOT CITED] [LATEST Version]
  92. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. PMID: 27943254 [NOT CITED] [LATEST Version]
  93. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. PMID: 25503105 [NOT CITED] [LATEST Version]
  94. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. PMID: 22336828 [NOT CITED] [OLD Version]
  95. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. PMID: 19370670 [NOT CITED] [OLD Version]
  96. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. PMID: 10796754 [NOT CITED] [LATEST Version]
  97. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. PMID: 19160192 [NOT CITED] [LATEST Version]
  98. Neoadjuvant chemoradiation for advanced primary vulvar cancer. PMID: 16856018 [NOT CITED] [LATEST Version]
  99. Neoadjuvant chemotherapy for invasive bladder cancer. PMID: 15846746 [NOT CITED] [LATEST Version]
  100. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. PMID: 27898991 [NOT CITED] [LATEST Version]
  101. Nitazoxanide for chronic hepatitis C. PMID: 24706397 [NOT CITED] [LATEST Version]
  102. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). PMID: 30001476 [NOT CITED] [LATEST Version]
  103. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. PMID: 29431861 [NOT CITED] [LATEST Version]
  104. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. PMID: 24715225 [NOT CITED] [OLD Version]
  105. Non-surgical versus surgical treatment for oesophageal cancer. PMID: 27021481 [NOT CITED] [LATEST Version]
  106. Nutritional support for liver disease. PMID: 22592729 [NOT CITED] [LATEST Version]
  107. Optical coherence tomography for diagnosing skin cancer in adults. PMID: 30521690 [NOT CITED] [LATEST Version]
  108. Oral and intrauterine progestogens for atypical endometrial hyperplasia. PMID: 30521671 [NOT CITED] [LATEST Version]
  109. Palliative biliary stents for obstructing pancreatic carcinoma. PMID: 16625598 [NOT CITED] [LATEST Version]
  110. Palliative biliary stents for obstructing pancreatic carcinoma. PMID: 16437477 [NOT CITED] [OLD Version]
  111. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. PMID: 29182797 [NOT CITED] [LATEST Version]
  112. Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 18425935 [NOT CITED] [LATEST Version]
  113. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. PMID: 28485814 [NOT CITED] [LATEST Version]
  114. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review. PMID: 30036453 [NOT CITED] [LATEST Version]
  115. Percutaneous ethanol injection for liver metastases. PMID: 23728679 [NOT CITED] [LATEST Version]
  116. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. PMID: 25620061 [NOT CITED] [LATEST Version]
  117. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. PMID: 19588401 [NOT CITED] [OLD Version]
  118. Perioperative nutrition for the treatment of bladder cancer by radical cystectomy. PMID: 31107970 [NOT CITED] [LATEST Version]
  119. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis. PMID: 28321877 [NOT CITED] [LATEST Version]
  120. Pharmacological interventions for acute hepatitis C infection. PMID: 30521693 [NOT CITED] [LATEST Version]
  121. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis. PMID: 28285495 [NOT CITED] [LATEST Version]
  122. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. PMID: 28368093 [NOT CITED] [LATEST Version]
  123. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. PMID: 31251387 [NOT CITED] [LATEST Version]
  124. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 24259251 [NOT CITED] [LATEST Version]
  125. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19821272 [NOT CITED] [OLD Version]
  126. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19588320 [NOT CITED] [OLD Version]
  127. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19160183 [NOT CITED] [OLD Version]
  128. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. PMID: 22419291 [NOT CITED] [LATEST Version]
  129. Postoperative tamoxifen for ductal carcinoma in situ. PMID: 23076938 [NOT CITED] [LATEST Version]
  130. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. PMID: 23235660 [NOT CITED] [LATEST Version]
  131. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. PMID: 17443515 [NOT CITED] [LATEST Version]
  132. Preoperative chemotherapy for resectable thoracic esophageal cancer. PMID: 25988291 [NOT CITED] [LATEST Version]
  133. Preoperative chemotherapy for resectable thoracic esophageal cancer. PMID: 11279723 [NOT CITED] [OLD Version]
  134. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. PMID: 30284239 [NOT CITED] [LATEST Version]
  135. Preoperative radiotherapy for esophageal carcinoma. PMID: 16235286 [NOT CITED] [LATEST Version]
  136. Preoperative radiotherapy for esophageal carcinoma. PMID: 11034728 [NOT CITED] [OLD Version]
  137. Preoperative radiotherapy for esophageal carcinoma. Oeosphageal Cancer Collaborative Group. PMID: 10796823 [NOT CITED] [LATEST Version]
  138. Primary groin irradiation vs primary groin surgery for early vulvar cancer. PMID: 11687151 [NOT CITED] [LATEST Version]
  139. Primary groin irradiation vs primary groin surgery for early vulvar cancer. PMID: 10908532 [NOT CITED] [OLD Version]
  140. Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. PMID: 20091590 [NOT CITED] [LATEST Version]
  141. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. PMID: 23440805 [NOT CITED] [LATEST Version]
  142. Prophylactic gastrojejunostomy for unresectable periampullary carcinoma. PMID: 23450583 [NOT CITED] [LATEST Version]
  143. Prophylactic gastrojejunostomy for unresectable periampullary carcinoma. PMID: 20927775 [NOT CITED] [OLD Version]
  144. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 26905229 [NOT CITED] [LATEST Version]
  145. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 25387229 [NOT CITED] [OLD Version]
  146. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. PMID: 21563148 [NOT CITED] [OLD Version]
  147. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. PMID: 24357457 [NOT CITED] [LATEST Version]
  148. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. PMID: 15106188 [NOT CITED] [LATEST Version]
  149. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. PMID: 12137670 [NOT CITED] [OLD Version]
  150. Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases. PMID: 19160311 [NOT CITED] [LATEST Version]
  151. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B. PMID: 30941748 [NOT CITED] [LATEST Version]
  152. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B. PMID: 31232459 [NOT CITED] [LATEST Version]
  153. Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults. PMID: 30521687 [NOT CITED] [LATEST Version]
  154. Retinoids for preventing the progression of cervical intra-epithelial neoplasia. PMID: 23740788 [NOT CITED] [LATEST Version]
  155. Retinoids for preventing the progression of cervical intra-epithelial neoplasia. PMID: 17943787 [NOT CITED] [OLD Version]
  156. Risk-reducing medications for primary breast cancer: a network meta-analysis. PMID: 31032883 [NOT CITED] [LATEST Version]
  157. Screening for oesophageal cancer. PMID: 23235651 [NOT CITED] [LATEST Version]
  158. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. PMID: 17943820 [NOT CITED] [LATEST Version]
  159. Short term benefits for laparoscopic colorectal resection. PMID: 16034888 [NOT CITED] [LATEST Version]
  160. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma. PMID: 31102534 [NOT CITED] [LATEST Version]
  161. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. PMID: 11687105 [NOT CITED] [LATEST Version]
  162. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. PMID: 16625534 [NOT CITED] [LATEST Version]
  163. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. PMID: 15106148 [NOT CITED] [OLD Version]
  164. Sun protection for preventing basal cell and squamous cell skin cancers. PMID: 27455163 [NOT CITED] [LATEST Version]
  165. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. PMID: 20464752 [NOT CITED] [LATEST Version]
  166. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. PMID: 19370683 [NOT CITED] [OLD Version]
  167. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. PMID: 23152243 [NOT CITED] [LATEST Version]
  168. Surgical interventions for early squamous cell carcinoma of the vulva. PMID: 10796849 [NOT CITED] [LATEST Version]
  169. Surgical management for upper urinary tract transitional cell carcinoma. PMID: 21491399 [NOT CITED] [LATEST Version]
  170. Surgical management of localised renal cell carcinoma. PMID: 20238346 [NOT CITED] [LATEST Version]
  171. Surgical resection versus liver transplant for patients with hepatocellular carcinoma. PMID: 23813393 [NOT CITED] [LATEST Version]
  172. Tamoxifen for hepatocellular carcinoma. PMID: 15266436 [NOT CITED] [LATEST Version]
  173. Targeted therapy for advanced renal cell carcinoma. PMID: 18425931 [NOT CITED] [LATEST Version]
  174. Teledermatology for diagnosing skin cancer in adults. PMID: 30521686 [NOT CITED] [LATEST Version]
  175. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers. PMID: 27562477 [NOT CITED] [LATEST Version]
  176. Topical interventions for genital lichen sclerosus. PMID: 22161424 [NOT CITED] [LATEST Version]
  177. Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps. PMID: 30109701 [NOT CITED] [LATEST Version]
  178. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. PMID: 21412886 [NOT CITED] [LATEST Version]
  179. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. PMID: 23633373 [NOT CITED] [LATEST Version]
  180. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. PMID: 22972145 [NOT CITED] [OLD Version]
  181. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. PMID: 30776082 [NOT CITED] [LATEST Version]
  182. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. PMID: 26934429 [NOT CITED] [LATEST Version]
  183. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. PMID: 30521688 [NOT CITED] [LATEST Version]
  184. Water infusion versus air insufflation for colonoscopy. PMID: 26011829 [NOT CITED] [LATEST Version]
  185. Wound drainage after axillary dissection for carcinoma of the breast. PMID: 24158902 [NOT CITED] [LATEST Version]
  186. Wound drainage following groin dissection for malignant disease in adults. PMID: 25387103 [NOT CITED] [LATEST Version]
  187. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. PMID: 26905230 [NOT CITED] [LATEST Version]
4049 Q954625 myelodysplastic syndrome Myelodysplastic syndrome B 3-Mid

Hematology-oncology
  1. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders. PMID: 26436602 [NOT CITED] [LATEST Version]
  2. Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. PMID: 29758592 [NOT CITED] [LATEST Version]
  3. Deferasirox for managing iron overload in people with myelodysplastic syndrome. PMID: 25348770 [NOT CITED] [LATEST Version]
  4. Deferasirox for managing iron overload in people with myelodysplastic syndrome. PMID: 21069694 [NOT CITED] [OLD Version]
  5. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. PMID: 25356860 [NOT CITED] [LATEST Version]
  6. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)). PMID: 30080246 [NOT CITED] [LATEST Version]
  7. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis. PMID: 28901021 [NOT CITED] [LATEST Version]
  8. Thrombopoietin mimetics for patients with myelodysplastic syndromes. PMID: 28962071 [NOT CITED] [LATEST Version]
3190 Q7228858 Poorly differentiated thyroid cancer Poorly differentiated thyroid cancer Stub 3-Mid

Hematology-oncology

 No matching publication found!
4041 Q948318 polycythemia vera Polycythemia vera Start 3-Mid

Hematology-oncology

 No matching publication found!
3921 Q2086442 B-cell prolymphocytic leukemia B-cell prolymphocytic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
3262 Q5558337 Giant-cell carcinoma of the lung Giant-cell carcinoma of the lung C 3-Mid

Hematology-oncology

Pulmonology

 No matching publication found!
3287 Q3616632 beta thalassemia Beta thalassemia B 3-Mid

Hematology-oncology

Medical genetics

 No matching publication found!
3326 Q3899003 Paraneoplastic pemphigus Paraneoplastic pemphigus B 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
3341 Q743545 fetal erythroblastosis Hemolytic disease of the newborn C 3-Mid

Hematology-oncology
  1. Immunoglobulin for alloimmune hemolytic disease in neonates. PMID: 29551014 [NOT CITED] [LATEST Version]
3395 Q823027 disseminated intravascular coagulation Disseminated intravascular coagulation B 3-Mid

Dermatology

Hematology-oncology

Pathology
  1. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. PMID: 23897323 [NOT CITED] [LATEST Version]
  2. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. PMID: 26978005 [NOT CITED] [LATEST Version]
  3. Antithrombin III for critically ill patients. PMID: 26858174 [NOT CITED] [LATEST Version]
  4. Epidural therapy for the treatment of severe pre-eclampsia in non labouring women. PMID: 29181841 [NOT CITED] [LATEST Version]
  5. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum. PMID: 21412921 [NOT CITED] [LATEST Version]
  6. TIPS versus paracentesis for cirrhotic patients with refractory ascites. PMID: 15266548 [NOT CITED] [LATEST Version]
  7. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 26107113 [NOT CITED] [LATEST Version]
  8. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 21678379 [NOT CITED] [OLD Version]
3400 Q826522 thyroid cancer Thyroid cancer B 3-Mid

Hematology-oncology

Pathology
  1. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer. PMID: 19821441 [NOT CITED] [LATEST Version]
  2. Angiogenesis-inhibitors for metastatic thyroid cancer. PMID: 20238360 [NOT CITED] [LATEST Version]
  3. Levothyroxine or minimally invasive therapies for benign thyroid nodules. PMID: 24941398 [NOT CITED] [LATEST Version]
  4. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer. PMID: 21069705 [NOT CITED] [LATEST Version]
  5. Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults. PMID: 26252202 [NOT CITED] [LATEST Version]
3449 Q7404869 Salivary gland–like carcinoma of the lung Salivary gland–like carcinoma of the lung Start 3-Mid

Hematology-oncology

 No matching publication found!
3489 Q1908194 vulvar cancer Vulvar cancer C 3-Mid

Hematology-oncology
  1. Neoadjuvant chemoradiation for advanced primary vulvar cancer. PMID: 16856018 [NOT CITED] [LATEST Version]
  2. Primary groin irradiation versus primary groin surgery for early vulvar cancer. PMID: 21563133 [NOT CITED] [LATEST Version]
  3. Primary groin irradiation vs primary groin surgery for early vulvar cancer. PMID: 11687151 [NOT CITED] [LATEST Version]
  4. Primary groin irradiation vs primary groin surgery for early vulvar cancer. PMID: 10908532 [NOT CITED] [OLD Version]
  5. Surgical interventions for early squamous cell carcinoma of the vulva. PMID: 10796849 [NOT CITED] [LATEST Version]
3610 Q1963588 hematopoietic system diseases Hematologic disease List 3-Mid

Hematology-oncology

 No matching publication found!
3613 Q1970052 Shwachman-Diamond syndrome Shwachman–Diamond syndrome C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
3680 Q864296 pituitary adenoma Pituitary adenoma C 3-Mid

Hematology-oncology

 No matching publication found!
3681 Q864868 bone marrow suppression Bone marrow suppression Start 3-Mid

Hematology-oncology
  1. Antiviral agents for treatment of herpes simplex virus infection in neonates. PMID: 19588350 [NOT CITED] [LATEST Version]
  2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. PMID: 27192092 [NOT CITED] [LATEST Version]
  3. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. PMID: 22972046 [NOT CITED] [OLD Version]
  4. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. PMID: 17253451 [NOT CITED] [OLD Version]
  5. Azathioprine for multiple sclerosis. PMID: 17943809 [NOT CITED] [LATEST Version]
  6. Chlorambucil for patients with primary biliary cirrhosis. PMID: 22972125 [NOT CITED] [LATEST Version]
  7. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. PMID: 29297205 [NOT CITED] [LATEST Version]
  8. Cyclosporine A for induction of remission in severe ulcerative colitis. PMID: 15674937 [NOT CITED] [LATEST Version]
  9. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. PMID: 16625599 [NOT CITED] [LATEST Version]
3693 Q882077 blastoma Blastoma Stub 3-Mid

Hematology-oncology

 No matching publication found!
3753 Q19000410 adenosquamous cell lung carcinoma Adenosquamous lung carcinoma C 3-Mid

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
3785 Q2090167 plasmacytoma Plasmacytoma C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
3791 Q2099138 placental insufficiency Placental insufficiency C 3-Mid

Hematology-oncology

Reproductive medicine
  1. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. PMID: 23884904 [NOT CITED] [LATEST Version]
  2. Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies). PMID: 10796118 [NOT CITED] [LATEST Version]
3797 Q2112719 prolymphocytic leukemia Prolymphocytic leukemia Stub 3-Mid

Hematology-oncology

 No matching publication found!
3884 Q912796 papilloma Papilloma Start 3-Mid

Hematology-oncology
  1. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer. PMID: 10796735 [NOT CITED] [LATEST Version]
  2. Local treatments for cutaneous warts. PMID: 12917913 [NOT CITED] [LATEST Version]
  3. Local treatments for cutaneous warts. PMID: 11406008 [NOT CITED] [OLD Version]
  4. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia. PMID: 26728940 [NOT CITED] [LATEST Version]
  5. Medical interventions for high grade vulval intraepithelial neoplasia. PMID: 21491403 [NOT CITED] [LATEST Version]
  6. Medical interventions for high-grade vulval intraepithelial neoplasia. PMID: 26284429 [NOT CITED] [LATEST Version]
  7. Photodynamic therapy for recurrent respiratory papillomatosis. PMID: 24898010 [NOT CITED] [LATEST Version]
3912 Q2070695 macrocytic anemia Macrocytic anemia Start 3-Mid

Hematology-oncology

 No matching publication found!
3964 Q936417 paraneoplastic syndrome Paraneoplastic syndrome C 3-Mid

Hematology-oncology

 No matching publication found!
2141 Q17126784 Hodgkin's lymphoma, nodular sclerosis Nodular sclerosis Stub 3-Mid

Hematology-oncology

 No matching publication found!
2357 Q6821200 mesenchymal chondrosarcoma Mesenchymal chondrosarcoma Stub 3-Mid

Hematology-oncology

 No matching publication found!
2080 Q6489151 T-cell large granular lymphocyte leukemia Large granular lymphocytic leukemia Start 3-Mid

Hematology-oncology

 No matching publication found!
820 Q5038170 carcinosarcoma Carcinosarcoma Start 3-Mid

Hematology-oncology
  1. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. PMID: 23450572 [NOT CITED] [LATEST Version]
  2. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. PMID: 21249682 [NOT CITED] [OLD Version]
  3. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma. PMID: 23450567 [NOT CITED] [LATEST Version]
933 Q1426491 thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura B 3-Mid

Dermatology

Hematology-oncology
  1. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. PMID: 19160220 [CITED] [LATEST Version]
  2. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. PMID: 10796426 [NOT CITED] [LATEST Version]
  3. Ticlopidine versus oral anticoagulation for coronary stenting. PMID: 11687144 [NOT CITED] [LATEST Version]
938 Q3109873 Evans' syndrome Evans syndrome Start 3-Mid

Hematology-oncology

 No matching publication found!
1013 Q582207 antiphospholipid syndrome Antiphospholipid syndrome C 3-Mid

Hematology-oncology

Neurology
  1. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. PMID: 15846729 [NOT CITED] [LATEST Version]
  2. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. PMID: 30004572 [NOT CITED] [LATEST Version]
  3. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. PMID: 28968483 [NOT CITED] [LATEST Version]
  4. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. PMID: 19160241 [NOT CITED] [LATEST Version]
1020 Q585285 thrombocytopenia Thrombocytopenia B 3-Mid

Hematology-oncology
  1. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 30702150 [NOT CITED] [LATEST Version]
  2. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 25386666 [NOT CITED] [OLD Version]
  3. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review. PMID: 27797129 [NOT CITED] [LATEST Version]
  4. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review. PMID: 27069420 [NOT CITED] [LATEST Version]
  5. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. PMID: 27548292 [NOT CITED] [LATEST Version]
  6. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. PMID: 21563140 [NOT CITED] [LATEST Version]
  7. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. PMID: 15674934 [NOT CITED] [OLD Version]
  8. Anticoagulation for patients with cancer and central venous catheters. PMID: 21491394 [NOT CITED] [LATEST Version]
  9. Anticoagulation for patients with cancer and central venous catheters. PMID: 21328283 [NOT CITED] [OLD Version]
  10. Anticoagulation for people with cancer and central venous catheters. PMID: 29856471 [NOT CITED] [LATEST Version]
  11. Anticoagulation for people with cancer and central venous catheters. PMID: 25318061 [NOT CITED] [OLD Version]
  12. Anticoagulation for perioperative thromboprophylaxis in people with cancer. PMID: 29993117 [NOT CITED] [LATEST Version]
  13. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. PMID: 24945634 [NOT CITED] [LATEST Version]
  14. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. PMID: 21678360 [NOT CITED] [OLD Version]
  15. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. PMID: 21491395 [NOT CITED] [OLD Version]
  16. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. PMID: 21328285 [NOT CITED] [OLD Version]
  17. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. PMID: 18254108 [NOT CITED] [OLD Version]
  18. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer. PMID: 29363105 [NOT CITED] [LATEST Version]
  19. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. PMID: 18425959 [NOT CITED] [LATEST Version]
  20. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. PMID: 25004410 [NOT CITED] [LATEST Version]
  21. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. PMID: 21678361 [NOT CITED] [OLD Version]
  22. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. PMID: 29920657 [NOT CITED] [LATEST Version]
  23. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. PMID: 17636845 [NOT CITED] [LATEST Version]
  24. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. PMID: 23897323 [NOT CITED] [LATEST Version]
  25. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. PMID: 26978005 [NOT CITED] [LATEST Version]
  26. Bortezomib for the treatment of multiple myeloma. PMID: 27096326 [NOT CITED] [LATEST Version]
  27. Chemotherapy for advanced non-small cell lung cancer in the elderly population. PMID: 26482542 [NOT CITED] [LATEST Version]
  28. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. PMID: 23949842 [NOT CITED] [LATEST Version]
  29. Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. PMID: 29758592 [NOT CITED] [LATEST Version]
  30. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 21833963 [NOT CITED] [LATEST Version]
  31. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. PMID: 26627708 [NOT CITED] [OLD Version]
  32. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. PMID: 26814707 [NOT CITED] [LATEST Version]
  33. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 28541603 [NOT CITED] [LATEST Version]
  34. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. PMID: 18425882 [NOT CITED] [LATEST Version]
  35. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. PMID: 16034876 [NOT CITED] [OLD Version]
  36. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. PMID: 11687025 [NOT CITED] [OLD Version]
  37. Cooling for newborns with hypoxic ischaemic encephalopathy. PMID: 23440789 [NOT CITED] [LATEST Version]
  38. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. PMID: 29297205 [NOT CITED] [LATEST Version]
  39. Cyclophosphamide for rheumatoid arthritis. PMID: 10796419 [NOT CITED] [LATEST Version]
  40. Cyclophosphamide for treating rheumatoid arthritis. PMID: 11034702 [NOT CITED] [LATEST Version]
  41. Early introduction of lipids to parenterally-fed preterm infants. PMID: 15846747 [NOT CITED] [LATEST Version]
  42. Erythropoietin or darbepoetin for patients with cancer. PMID: 23235597 [NOT CITED] [LATEST Version]
  43. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. PMID: 29624208 [NOT CITED] [LATEST Version]
  44. Heparin for assisted reproduction. PMID: 23955506 [NOT CITED] [LATEST Version]
  45. Heparin for prolonging peripheral intravenous catheter use in neonates. PMID: 16235300 [NOT CITED] [LATEST Version]
  46. Heparin for prolonging peripheral intravenous catheter use in neonates. PMID: 12519576 [NOT CITED] [OLD Version]
  47. Heparin for the treatment of thrombosis in neonates. PMID: 27820879 [NOT CITED] [LATEST Version]
  48. Heparin versus normal saline for patency of arterial lines. PMID: 24825673 [NOT CITED] [LATEST Version]
  49. Heparin versus placebo for acute coronary syndromes. PMID: 18425889 [NOT CITED] [LATEST Version]
  50. Heparin versus placebo for non-ST elevation acute coronary syndromes. PMID: 24972265 [NOT CITED] [LATEST Version]
  51. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. PMID: 24569952 [NOT CITED] [LATEST Version]
  52. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias. PMID: 27755646 [NOT CITED] [LATEST Version]
  53. Interferon alpha for chronic hepatitis D. PMID: 22161394 [NOT CITED] [LATEST Version]
  54. Interleukin 2 receptor antagonists for kidney transplant recipients. PMID: 20091551 [NOT CITED] [LATEST Version]
  55. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission. PMID: 26544114 [NOT CITED] [LATEST Version]
  56. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis. PMID: 25860512 [NOT CITED] [LATEST Version]
  57. Linezolid for drug-resistant pulmonary tuberculosis. PMID: 30893466 [NOT CITED] [LATEST Version]
  58. Linezolid versus vancomycin for skin and soft tissue infections. PMID: 26758498 [NOT CITED] [LATEST Version]
  59. Linezolid versus vancomycin for skin and soft tissue infections. PMID: 23846850 [NOT CITED] [OLD Version]
  60. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. PMID: 24771319 [NOT CITED] [LATEST Version]
  61. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. PMID: 18843725 [NOT CITED] [OLD Version]
  62. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. PMID: 24966161 [NOT CITED] [LATEST Version]
  63. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. PMID: 22071865 [NOT CITED] [OLD Version]
  64. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. PMID: 12535430 [NOT CITED] [LATEST Version]
  65. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. PMID: 19821437 [NOT CITED] [LATEST Version]
  66. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. PMID: 26633102 [NOT CITED] [LATEST Version]
  67. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 28892556 [NOT CITED] [LATEST Version]
  68. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. PMID: 20091569 [NOT CITED] [LATEST Version]
  69. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. PMID: 24585509 [NOT CITED] [LATEST Version]
  70. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer. PMID: 24142521 [NOT CITED] [LATEST Version]
  71. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. PMID: 23835762 [NOT CITED] [LATEST Version]
  72. Pentasaccharides for the prevention of venous thromboembolism. PMID: 27797404 [NOT CITED] [LATEST Version]
  73. Pentasaccharides for the treatment of deep vein thrombosis. PMID: 29199766 [NOT CITED] [LATEST Version]
  74. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 26233609 [NOT CITED] [LATEST Version]
  75. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 18843733 [NOT CITED] [OLD Version]
  76. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. PMID: 28073178 [NOT CITED] [LATEST Version]
  77. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. PMID: 25806562 [NOT CITED] [LATEST Version]
  78. Prophylactic platelet transfusions prior to surgery for people with a low platelet count. PMID: 30221749 [NOT CITED] [LATEST Version]
  79. Quinine for muscle cramps. PMID: 25842375 [NOT CITED] [LATEST Version]
  80. Quinine for muscle cramps. PMID: 21154358 [NOT CITED] [OLD Version]
  81. Radioisotopes for metastatic bone pain. PMID: 21735393 [NOT CITED] [LATEST Version]
  82. Radioisotopes for metastatic bone pain. PMID: 14583970 [NOT CITED] [OLD Version]
  83. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia. PMID: 23152253 [NOT CITED] [LATEST Version]
  84. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). PMID: 22071858 [NOT CITED] [LATEST Version]
  85. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. PMID: 24026801 [NOT CITED] [LATEST Version]
  86. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. PMID: 16625599 [NOT CITED] [LATEST Version]
  87. Thrombopoietin mimetics for patients with myelodysplastic syndromes. PMID: 28962071 [NOT CITED] [LATEST Version]
  88. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours. PMID: 29178132 [NOT CITED] [LATEST Version]
  89. Ticlopidine versus oral anticoagulation for coronary stenting. PMID: 11687144 [NOT CITED] [LATEST Version]
  90. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. PMID: 27731885 [NOT CITED] [LATEST Version]
  91. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 22972111 [NOT CITED] [LATEST Version]
  92. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 28431186 [NOT CITED] [LATEST Version]
  93. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. PMID: 29709077 [NOT CITED] [LATEST Version]
  94. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. PMID: 27218879 [NOT CITED] [OLD Version]
  95. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. PMID: 27057148 [NOT CITED] [OLD Version]
1039 Q1435822 neutropenia Neutropenia B 3-Mid

Hematology-oncology
  1. Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. PMID: 25188673 [NOT CITED] [LATEST Version]
  2. Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia. PMID: 10908480 [NOT CITED] [LATEST Version]
  3. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. PMID: 25188769 [NOT CITED] [LATEST Version]
  4. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. PMID: 12076388 [NOT CITED] [OLD Version]
  5. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients. PMID: 10908468 [NOT CITED] [LATEST Version]
  6. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. PMID: 21069685 [NOT CITED] [LATEST Version]
  7. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. PMID: 20166083 [NOT CITED] [LATEST Version]
  8. Antipsychotic medication for childhood-onset schizophrenia. PMID: 17636744 [NOT CITED] [LATEST Version]
  9. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. PMID: 23813455 [NOT CITED] [LATEST Version]
  10. Bortezomib for the treatment of multiple myeloma. PMID: 27096326 [NOT CITED] [LATEST Version]
  11. Chemotherapy for advanced non-small cell lung cancer in the elderly population. PMID: 26482542 [NOT CITED] [LATEST Version]
  12. Chemotherapy for children with medulloblastoma. PMID: 25879092 [NOT CITED] [LATEST Version]
  13. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. PMID: 25400254 [NOT CITED] [LATEST Version]
  14. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. PMID: 17443560 [NOT CITED] [LATEST Version]
  15. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. PMID: 23949842 [NOT CITED] [LATEST Version]
  16. Colony stimulating factors for chemotherapy induced febrile neutropenia. PMID: 12917942 [NOT CITED] [LATEST Version]
  17. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. PMID: 16034921 [NOT CITED] [LATEST Version]
  18. Colony-stimulating factors for chemotherapy-induced febrile neutropenia. PMID: 25356786 [NOT CITED] [LATEST Version]
  19. Combination versus sequential single agent chemotherapy for metastatic breast cancer. PMID: 24347031 [NOT CITED] [LATEST Version]
  20. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 21833963 [NOT CITED] [LATEST Version]
  21. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. PMID: 28541603 [NOT CITED] [LATEST Version]
  22. Concurrent chemoradiotherapy in non-small cell lung cancer. PMID: 20556756 [NOT CITED] [LATEST Version]
  23. Concurrent chemoradiotherapy in non-small cell lung cancer. PMID: 15495029 [NOT CITED] [OLD Version]
  24. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia. PMID: 23963793 [NOT CITED] [LATEST Version]
  25. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer. PMID: 30605229 [NOT CITED] [LATEST Version]
  26. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856062 [NOT CITED] [LATEST Version]
  27. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. PMID: 27943261 [NOT CITED] [LATEST Version]
  28. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. PMID: 28654140 [NOT CITED] [LATEST Version]
  29. G-CSF and GM-CSF for treating or preventing neonatal infections. PMID: 12917944 [NOT CITED] [LATEST Version]
  30. Galactomannan detection for invasive aspergillosis in immunocompromised patients. PMID: 26716951 [NOT CITED] [LATEST Version]
  31. Galactomannan detection for invasive aspergillosis in immunocompromized patients. PMID: 18843747 [NOT CITED] [LATEST Version]
  32. Gefitinib for advanced non-small cell lung cancer. PMID: 29336009 [NOT CITED] [LATEST Version]
  33. Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes. PMID: 26880256 [NOT CITED] [LATEST Version]
  34. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. PMID: 21975741 [NOT CITED] [LATEST Version]
  35. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. PMID: 19160254 [NOT CITED] [LATEST Version]
  36. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. PMID: 26118415 [NOT CITED] [LATEST Version]
  37. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. PMID: 16034970 [NOT CITED] [LATEST Version]
  38. Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction. PMID: 27128488 [NOT CITED] [LATEST Version]
  39. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. PMID: 17443546 [NOT CITED] [LATEST Version]
  40. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma. PMID: 12519588 [NOT CITED] [LATEST Version]
  41. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 18843642 [NOT CITED] [LATEST Version]
  42. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 14974009 [NOT CITED] [OLD Version]
  43. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. PMID: 15266474 [NOT CITED] [OLD Version]
  44. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias. PMID: 27755646 [NOT CITED] [LATEST Version]
  45. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission. PMID: 26544114 [NOT CITED] [LATEST Version]
  46. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer. PMID: 26869023 [NOT CITED] [LATEST Version]
  47. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis. PMID: 25860512 [NOT CITED] [LATEST Version]
  48. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856064 [NOT CITED] [LATEST Version]
  49. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. PMID: 27107610 [NOT CITED] [LATEST Version]
  50. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. PMID: 22972091 [NOT CITED] [OLD Version]
  51. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer. PMID: 27356090 [NOT CITED] [LATEST Version]
  52. Oral deferiprone for iron chelation in people with thalassaemia. PMID: 23966105 [NOT CITED] [LATEST Version]
  53. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. PMID: 24105485 [NOT CITED] [LATEST Version]
  54. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. PMID: 15495074 [NOT CITED] [OLD Version]
  55. Oral versus intravenous fluoropyrimidines for colorectal cancer. PMID: 28752564 [NOT CITED] [LATEST Version]
  56. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. PMID: 24585509 [NOT CITED] [LATEST Version]
  57. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer. PMID: 24142521 [NOT CITED] [LATEST Version]
  58. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. PMID: 23076939 [NOT CITED] [LATEST Version]
  59. Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer. PMID: 30168576 [NOT CITED] [LATEST Version]
  60. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. PMID: 24277633 [NOT CITED] [LATEST Version]
  61. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. PMID: 26687844 [NOT CITED] [LATEST Version]
  62. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. PMID: 19160320 [NOT CITED] [LATEST Version]
  63. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 25269391 [NOT CITED] [LATEST Version]
  64. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 17636808 [NOT CITED] [OLD Version]
  65. Purine antagonists for chronic lymphocytic leukaemia. PMID: 16856041 [NOT CITED] [LATEST Version]
  66. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. PMID: 25989478 [NOT CITED] [LATEST Version]
  67. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia. PMID: 23152253 [NOT CITED] [LATEST Version]
  68. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. PMID: 25188768 [NOT CITED] [LATEST Version]
  69. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. PMID: 12076377 [NOT CITED] [OLD Version]
  70. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. PMID: 11034669 [NOT CITED] [OLD Version]
  71. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. PMID: 10796687 [NOT CITED] [OLD Version]
  72. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. PMID: 30776132 [NOT CITED] [LATEST Version]
  73. Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. PMID: 21563139 [NOT CITED] [LATEST Version]
  74. Taxanes for adjuvant treatment of early breast cancer. PMID: 31476253 [NOT CITED] [LATEST Version]
  75. Teriflunomide for multiple sclerosis. PMID: 27003123 [NOT CITED] [LATEST Version]
  76. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. PMID: 10796426 [NOT CITED] [LATEST Version]
  77. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. PMID: 19821273 [NOT CITED] [LATEST Version]
  78. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. PMID: 15106163 [NOT CITED] [LATEST Version]
  79. Thymic peptides for treatment of cancer patients. PMID: 21328265 [NOT CITED] [LATEST Version]
  80. Ticlopidine versus oral anticoagulation for coronary stenting. PMID: 11687144 [NOT CITED] [LATEST Version]
  81. TNF-α blockers for the treatment of Kawasaki disease in children. PMID: 31425625 [NOT CITED] [LATEST Version]
  82. Trastuzumab-containing regimens for metastatic breast cancer. PMID: 24919460 [NOT CITED] [LATEST Version]
  83. Tricyclic and related drugs for nocturnal enuresis in children. PMID: 26789925 [NOT CITED] [LATEST Version]
  84. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia. PMID: 26899263 [NOT CITED] [LATEST Version]
  85. Voriconazole versus amphotericin B in cancer patients with neutropenia. PMID: 16437492 [NOT CITED] [LATEST Version]
  86. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. PMID: 24563222 [NOT CITED] [LATEST Version]
1047 Q3237103 leukostasis Leukostasis Start 3-Mid

Hematology-oncology

 No matching publication found!
1067 Q5196687 cutaneous T cell lymphoma Cutaneous T cell lymphoma Start 3-Mid

Dermatology

Hematology-oncology
  1. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. PMID: 23986525 [NOT CITED] [LATEST Version]
  2. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. PMID: 22258991 [NOT CITED] [OLD Version]
  3. Interventions for mycosis fungoides. PMID: 22972128 [NOT CITED] [LATEST Version]
1103 Q591256 MALT lymphoma MALT lymphoma Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1143 Q3281380 X-linked lymphoproliferative disease X-linked lymphoproliferative disease Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
2140 Q17126040 Transfusion associated circulatory overload Transfusion associated circulatory overload Start 3-Mid

Hematology-oncology
  1. Loop diuretics for patients receiving blood transfusions. PMID: 25685898 [NOT CITED] [LATEST Version]
1245 Q3493538 thyroid medullary carcinoma Medullary thyroid cancer B 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
1286 Q5464661 Follicular large-cell lymphoma Follicular large-cell lymphoma C 3-Mid

Hematology-oncology

 No matching publication found!
1287 Q5464665 follicular thyroid cancer Follicular thyroid cancer Start 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
1310 Q612108 acute promyelocytic leukemia Acute promyelocytic leukemia C 3-Mid

Hematology-oncology
  1. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission. PMID: 23543579 [NOT CITED] [LATEST Version]
  2. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 26107113 [NOT CITED] [LATEST Version]
1356 Q5370233 Embryonal rhabdomyosarcoma Embryonal rhabdomyosarcoma Stub 3-Mid

Hematology-oncology

 No matching publication found!
1430 Q2845432 ehrlichiosis Ehrlichiosis C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1474 Q3049302 human monocytic ehrlichiosis Human monocytotropic ehrlichiosis Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1491 Q3144934 HFE hereditary haemochromatosis HFE hereditary haemochromatosis B 3-Mid

Hematology-oncology

Medical genetics

 No matching publication found!
819 Q5038165 Carcinoma ex-pleomorphic adenoma Carcinoma ex pleomorphic adenoma Start 3-Mid

Hematology-oncology

Pathology

 No matching publication found!
1512 Q1456558 angular cheilitis Angular cheilitis B 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
797 Q4955921 Brainstem glioma Brainstem glioma Start 3-Mid

Hematology-oncology
  1. Radiotherapy for diffuse brainstem glioma in children and young adults. PMID: 27378212 [NOT CITED] [LATEST Version]
641 Q1393718 hemophilia C Haemophilia C C 3-Mid

Hematology-oncology

Medical genetics

 No matching publication found!
67 Q201299 hairy cell leukemia Hairy cell leukemia B 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
72 Q268713 mantle cell lymphoma Mantle cell lymphoma C 3-Mid

Hematology-oncology
  1. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. PMID: 22972131 [NOT CITED] [LATEST Version]
  2. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. PMID: 17943799 [NOT CITED] [LATEST Version]
93 Q177755 astrocytoma Astrocytoma Start 3-Mid

Hematology-oncology

Neurology
  1. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas. PMID: 24833028 [NOT CITED] [LATEST Version]
  2. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. PMID: 26118544 [NOT CITED] [LATEST Version]
  3. Rapamycin and rapalogs for tuberous sclerosis complex. PMID: 27409709 [NOT CITED] [LATEST Version]
107 Q296104 Activated protein C resistance Activated protein C resistance Start 3-Mid

Hematology-oncology

 No matching publication found!
136 Q272741 adenoma Adenoma Start 3-Mid

Hematology-oncology
  1. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. PMID: 18254022 [NOT CITED] [LATEST Version]
  2. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. PMID: 16034903 [NOT CITED] [OLD Version]
  3. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. PMID: 14974021 [NOT CITED] [OLD Version]
  4. Dietary fibre for the prevention of colorectal adenomas and carcinomas. PMID: 12076480 [NOT CITED] [LATEST Version]
  5. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. PMID: 28064440 [NOT CITED] [LATEST Version]
  6. Dietary flavonoid for preventing colorectal neoplasms. PMID: 22895989 [NOT CITED] [LATEST Version]
  7. Elective surgery for benign liver tumours. PMID: 17253542 [NOT CITED] [LATEST Version]
  8. Narrow band imaging versus conventional white light colonoscopy for the detection of colorectal polyps. PMID: 22258983 [NOT CITED] [LATEST Version]
  9. Single dose oral rofecoxib for acute postoperative pain in adults. PMID: 19821329 [NOT CITED] [LATEST Version]
  10. Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps. PMID: 30109701 [NOT CITED] [LATEST Version]
  11. Water infusion versus air insufflation for colonoscopy. PMID: 26011829 [NOT CITED] [LATEST Version]
151 Q123251 follicular lymphoma Follicular lymphoma C 3-Mid

Hematology-oncology
  1. Anthracycline-containing regimens for treatment of follicular lymphoma in adults. PMID: 23832787 [NOT CITED] [LATEST Version]
  2. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. PMID: 22972131 [NOT CITED] [LATEST Version]
  3. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. PMID: 17943799 [NOT CITED] [LATEST Version]
  4. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. PMID: 22258971 [NOT CITED] [LATEST Version]
  5. Interferon-alpha for maintenance of follicular lymphoma. PMID: 20091564 [NOT CITED] [LATEST Version]
  6. Rituximab as maintenance therapy for patients with follicular lymphoma. PMID: 19370640 [NOT CITED] [LATEST Version]
152 Q124292 cholangiocarcinoma Cholangiocarcinoma FA 3-Mid

Gastroenterology

Hematology-oncology

Pathology
  1. Glucocorticosteroids for primary sclerosing cholangitis. PMID: 20091555 [NOT CITED] [LATEST Version]
  2. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. PMID: 28417463 [NOT CITED] [LATEST Version]
302 Q337585 Intraductal carcinoma Ductal carcinoma in situ C 3-Mid

Hematology-oncology
  1. Decision aids for people considering taking part in clinical trials. PMID: 26613337 [NOT CITED] [LATEST Version]
  2. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. PMID: 27898991 [NOT CITED] [LATEST Version]
  3. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 24259251 [CITED] [LATEST Version]
  4. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19821272 [NOT CITED] [OLD Version]
  5. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19588320 [NOT CITED] [OLD Version]
  6. Post-operative radiotherapy for ductal carcinoma in situ of the breast. PMID: 19160183 [NOT CITED] [OLD Version]
  7. Postoperative tamoxifen for ductal carcinoma in situ. PMID: 23076938 [NOT CITED] [LATEST Version]
306 Q339547 carcinoid syndrome Carcinoid syndrome Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
326 Q467635 multiple myeloma Multiple myeloma B 3-Mid

Hematology-oncology
  1. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma. PMID: 26484982 [NOT CITED] [LATEST Version]
  2. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 30702150 [NOT CITED] [LATEST Version]
  3. Aerobic physical exercise for adult patients with haematological malignancies. PMID: 25386666 [NOT CITED] [OLD Version]
  4. Bisphosphonates for advanced prostate cancer. PMID: 17054286 [NOT CITED] [LATEST Version]
  5. Bisphosphonates for breast cancer. PMID: 16034900 [NOT CITED] [LATEST Version]
  6. Bisphosphonates for breast cancer. PMID: 11869664 [NOT CITED] [OLD Version]
  7. Bisphosphonates in multiple myeloma. PMID: 20238320 [NOT CITED] [LATEST Version]
  8. Bisphosphonates in multiple myeloma. PMID: 12137679 [NOT CITED] [OLD Version]
  9. Bisphosphonates in multiple myeloma. PMID: 11687178 [NOT CITED] [OLD Version]
  10. Bisphosphonates in multiple myeloma: a network meta-analysis. PMID: 22592688 [NOT CITED] [LATEST Version]
  11. Bisphosphonates in multiple myeloma: an updated network meta-analysis. PMID: 29253322 [NOT CITED] [LATEST Version]
  12. Bortezomib for the treatment of multiple myeloma. PMID: 27096326 [NOT CITED] [LATEST Version]
  13. Early versus deferred treatment for early stage multiple myeloma. PMID: 12535504 [NOT CITED] [LATEST Version]
  14. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. PMID: 23076906 [NOT CITED] [LATEST Version]
  15. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. PMID: 27906452 [NOT CITED] [LATEST Version]
  16. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. PMID: 25171736 [NOT CITED] [OLD Version]
  17. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. PMID: 21412895 [NOT CITED] [LATEST Version]
334 Q1318384 oligodendroglioma Oligodendroglioma C 3-Mid

Hematology-oncology

Neurology

Pathology
  1. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. PMID: 26118544 [NOT CITED] [LATEST Version]
340 Q134003 hemophilia Haemophilia C 3-Mid

Hematology-oncology

Medical genetics
  1. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors. PMID: 28944952 [NOT CITED] [LATEST Version]
  2. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 21901684 [NOT CITED] [LATEST Version]
  3. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 16625581 [NOT CITED] [OLD Version]
  4. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. PMID: 15846666 [NOT CITED] [OLD Version]
  5. Exercise for haemophilia. PMID: 27992070 [NOT CITED] [LATEST Version]
  6. Interventions for treating acute bleeding episodes in people with acquired hemophilia A. PMID: 25165992 [NOT CITED] [LATEST Version]
  7. Rituximab for eradicating inhibitors in people with acquired haemophilia A. PMID: 27387850 [NOT CITED] [LATEST Version]
  8. Rituximab for treating inhibitors in people with inherited severe hemophilia. PMID: 28685500 [NOT CITED] [LATEST Version]
  9. Rituximab for treating inhibitors in people with inherited severe hemophilia. PMID: 25841099 [NOT CITED] [OLD Version]
375 Q185137 thalassemia Thalassemia B 3-Mid

Hematology-oncology

Medical genetics
  1. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. PMID: 27574910 [NOT CITED] [LATEST Version]
  2. Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia. PMID: 31250923 [NOT CITED] [LATEST Version]
  3. Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia. PMID: 29861660 [NOT CITED] [OLD Version]
  4. Deferasirox for managing iron overload in people with thalassaemia. PMID: 22336831 [NOT CITED] [LATEST Version]
  5. Hematopoietic stem cell transplantation for people with ß-thalassaemia major. PMID: 27900772 [CITED] [LATEST Version]
  6. Hematopoietic stem cell transplantation for people with ß-thalassaemia major. PMID: 25316103 [NOT CITED] [OLD Version]
  7. Hematopoietic stem cell transplantation for people with ß-thalassaemia major. PMID: 21975785 [NOT CITED] [OLD Version]
388 Q356372 uveal melanoma Uveal melanoma C 3-Mid

Dermatology

Hematology-oncology

Ophthalmology

 No matching publication found!
414 Q162266 hemolytic-uremic syndrome Hemolytic-uremic syndrome B 3-Mid

Hematology-oncology

 No matching publication found!
493 Q475260 Klatskin's tumor Klatskin tumor Start 3-Mid

Hematology-oncology

 No matching publication found!
499 Q1328805 bone neoplasm Bone tumor C 3-Mid

Hematology-oncology

 No matching publication found!
561 Q496812 leukopenia Leukopenia Start 3-Mid

Hematology-oncology
  1. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. PMID: 16856005 [NOT CITED] [LATEST Version]
  2. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. PMID: 10796557 [NOT CITED] [LATEST Version]
  3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. PMID: 27783843 [NOT CITED] [LATEST Version]
  4. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. PMID: 23633304 [NOT CITED] [OLD Version]
  5. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. PMID: 20556747 [NOT CITED] [OLD Version]
  6. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. PMID: 19821270 [NOT CITED] [OLD Version]
  7. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. PMID: 26517527 [NOT CITED] [LATEST Version]
  8. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. PMID: 25400254 [NOT CITED] [LATEST Version]
  9. Chinese herbal medicines for induction of remission in advanced or late gastric cancer. PMID: 23633324 [NOT CITED] [LATEST Version]
  10. Chinese herbal medicines for induction of remission in advanced or late gastric cancer. PMID: 20091570 [NOT CITED] [OLD Version]
  11. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. PMID: 29297205 [NOT CITED] [LATEST Version]
  12. Dimethyl fumarate for multiple sclerosis. PMID: 25900414 [NOT CITED] [LATEST Version]
  13. Interferon alpha for chronic hepatitis D. PMID: 22161394 [NOT CITED] [LATEST Version]
  14. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis. PMID: 31513295 [NOT CITED] [LATEST Version]
  15. Interventions for renal vasculitis in adults. PMID: 18646089 [NOT CITED] [LATEST Version]
  16. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. PMID: 30480754 [NOT CITED] [LATEST Version]
  17. Platinum containing regimens for metastatic breast cancer. PMID: 15266482 [NOT CITED] [LATEST Version]
  18. Platinum containing regimens for metastatic breast cancer. PMID: 15106201 [NOT CITED] [OLD Version]
  19. Platinum-containing regimens for metastatic breast cancer. PMID: 28643430 [NOT CITED] [LATEST Version]
  20. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 25269391 [NOT CITED] [LATEST Version]
  21. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 17636808 [NOT CITED] [OLD Version]
  22. Propylthiouracil for alcoholic liver disease. PMID: 21678335 [NOT CITED] [LATEST Version]
  23. Propylthiouracil for alcoholic liver disease. PMID: 16235302 [NOT CITED] [OLD Version]
  24. Propylthiouracil for alcoholic liver disease. PMID: 12076451 [NOT CITED] [OLD Version]
  25. Single agent versus combination chemotherapy for metastatic breast cancer. PMID: 15846660 [NOT CITED] [LATEST Version]
  26. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. PMID: 26845108 [NOT CITED] [LATEST Version]
  27. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. PMID: 30776082 [NOT CITED] [LATEST Version]
  28. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease. PMID: 29756637 [NOT CITED] [LATEST Version]
567 Q1342955 penile cancer Penile cancer C 3-Mid

Hematology-oncology

 No matching publication found!
702 Q7900855 urogenital neoplasm Urogenital neoplasm Stub 3-Mid

Hematology-oncology

 No matching publication found!
1526 Q3298999 microcytic anemia Microcytic anemia Start 3-Mid

Hematology-oncology

Medical genetics

 No matching publication found!
1235 Q3410985 purpura fulminans Purpura fulminans Start 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
12865 Q1164529 renal cell carcinoma Renal cell carcinoma B 3-Mid

Hematology-oncology

Nephrology

Pathology
  1. Immunotherapy for advanced renal cell cancer. PMID: 15674877 [NOT CITED] [LATEST Version]
  2. Immunotherapy for advanced renal cell cancer. PMID: 10908496 [NOT CITED] [OLD Version]
  3. Immunotherapy for metastatic renal cell carcinoma. PMID: 28504837 [NOT CITED] [LATEST Version]
  4. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). PMID: 30001476 [NOT CITED] [LATEST Version]
  5. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. PMID: 28485814 [NOT CITED] [LATEST Version]
  6. Surgical management of localised renal cell carcinoma. PMID: 20238346 [NOT CITED] [LATEST Version]
  7. Targeted therapy for advanced renal cell carcinoma. PMID: 18425931 [NOT CITED] [LATEST Version]
1527 Q3299714 normocytic anemia Normocytic anemia Start 3-Mid

Hematology-oncology

 No matching publication found!
1780 Q3832897 thyroid lymphoma Thyroid lymphoma C 3-Mid

Hematology-oncology

 No matching publication found!
1731 Q13641482 kidney neoplasm Kidney tumour Start 3-Mid

Hematology-oncology

 No matching publication found!
1722 Q5598281 gray zone lymphoma Gray zone lymphoma Stub 3-Mid

Hematology-oncology

 No matching publication found!
1700 Q5571213 glomangiosarcoma Glomangiosarcoma Stub 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1875 Q1542410 thrombogavitis Thrombocythemia Start 3-Mid

Hematology-oncology

 No matching publication found!
1654 Q638729 autoimmune thrombocytopenic purpura Immune thrombocytopenic purpura B 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1778 Q3832899 primary effusion lymphoma Primary effusion lymphoma Start 3-Mid

Hematology-oncology

 No matching publication found!
1946 Q16240919 Blastic NK cell lymphoma Blastic plasmacytoid dendritic cell neoplasm B 3-Mid

Hematology-oncology

 No matching publication found!
1947 Q658873 radiation burn Radiation burn C 3-Mid

Dermatology

Hematology-oncology

 No matching publication found!
1914 Q5731687 hepatic veno-occlusive disease Hepatic veno-occlusive disease Start 3-Mid

Hematology-oncology
  1. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. PMID: 26017019 [NOT CITED] [LATEST Version]
1975 Q1570013 thrombophilia Thrombophilia GA 3-Mid

Hematology-oncology
  1. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. PMID: 15846729 [NOT CITED] [LATEST Version]
  2. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. PMID: 24995856 [NOT CITED] [LATEST Version]
  3. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. PMID: 19160241 [NOT CITED] [LATEST Version]
  4. Heparin for pregnant women with acquired or inherited thrombophilias. PMID: 12804477 [NOT CITED] [LATEST Version]
  5. Heparin for the treatment of thrombosis in neonates. PMID: 27820879 [NOT CITED] [LATEST Version]
  6. Thrombophilia testing for prevention of recurrent venous thromboembolism. PMID: 23235639 [NOT CITED] [LATEST Version]
  7. Thrombophilia testing for prevention of recurrent venous thromboembolism. PMID: 19160316 [NOT CITED] [OLD Version]
2028 Q5965479 uterine sarcoma Uterine sarcoma Start 3-Mid

Hematology-oncology

 No matching publication found!
1560 Q627373 Pleomorphic xanthoastrocytoma Pleomorphic xanthoastrocytoma C 3-Mid

Hematology-oncology

 No matching publication found!
1538 Q1504713 leiomyosarcoma Leiomyosarcoma Start 3-Mid

Dermatology

Hematology-oncology

Pathology
  1. Treatment for leiomyosarcoma and leiomyoma in children with HIV infection. PMID: 20464756 [NOT CITED] [LATEST Version]
577 Q2736268 mucoepidermoid carcinoma Mucoepidermoid carcinoma Start 4-Low

Hematology-oncology

Pathology

 No matching publication found!
1840 Q16938550 Refractory anemia with ring sideroblasts Refractory anemia with ring sideroblasts Stub 4-Low

Hematology-oncology

 No matching publication found!
642 Q1393725 factor XIII deficiency Factor XIII deficiency Start 4-Low

Hematology-oncology

 No matching publication found!
73 Q268832 Accelerated phase chronic myelogenous leukemia Accelerated phase chronic myelogenous leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!
4091 Q48817400 vaginal melanoma Vaginal melanoma Stub 4-Low

Hematology-oncology

 No matching publication found!
4465 Q1088057 Chronic neutrophilic leukemia Chronic neutrophilic leukemia Start 4-Low

Hematology-oncology

 No matching publication found!
668 Q3043153 protein S deficiency Protein S deficiency C 4-Low

Hematology-oncology

 No matching publication found!
1801 Q6030096 Inflammatory myeloblastic tumor Inflammatory myeloblastic tumor Stub 4-Low

Gastroenterology

Hematology-oncology

 No matching publication found!
757 Q1368780 Essential thrombocytosis Essential thrombocythemia Start 4-Low

Hematology-oncology

 No matching publication found!
3970 Q938329 Richter's syndrome Richter's transformation Start 4-Low

Hematology-oncology

 No matching publication found!
2015 Q5958533 Hyperprothrombinemia Hyperprothrombinemia Stub 4-Low

Hematology-oncology

 No matching publication found!
1779 Q3832896 Nodal marginal zone B cell lymphoma Nodal marginal zone B cell lymphoma Stub 4-Low

Hematology-oncology

 No matching publication found!
2493 Q7045267 No reflow phenomenon No reflow phenomenon Stub 4-Low

Hematology-oncology

 No matching publication found!
4069 Q2298020 hereditary elliptocytosis Hereditary elliptocytosis B 4-Low

Hematology-oncology

Medical genetics

 No matching publication found!
1987 Q3709312 dyskeratosis congenita Dyskeratosis congenita Start 4-Low

Dermatology

Hematology-oncology

 No matching publication found!
548 Q486090 Anaplastic large-cell lymphoma Anaplastic large-cell lymphoma C 4-Low

Hematology-oncology

Pathology

 No matching publication found!
1984 Q3704732 antithrombin III deficiency Antithrombin III deficiency Start 4-Low

Hematology-oncology

 No matching publication found!
4284 Q992139 human granulocytic anaplasmosis Human granulocytic anaplasmosis C 4-Low

Hematology-oncology

 No matching publication found!
2252 Q3843804 Acute erythroid leukemia Acute erythroid leukemia Start 4-Low

Hematology-oncology

 No matching publication found!
2402 Q17155516 Mucinous cystadenocarcinoma of the lung Mucinous cystadenocarcinoma of the lung Start 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
2300 Q17002910 ABO hemolytic disease of the newborn Hemolytic disease of the newborn (ABO) Start 4-Low

Hematology-oncology

 No matching publication found!
4346 Q2551272 Hypereosinophilic syndrome Hypereosinophilic syndrome Start 4-Low

Dermatology

Hematology-oncology

 No matching publication found!
4347 Q2553422 POEMS syndrome POEMS syndrome Start 4-Low

Dermatology

Hematology-oncology
  1. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. PMID: 22696361 [NOT CITED] [LATEST Version]
  2. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. PMID: 18843731 [NOT CITED] [OLD Version]
2376 Q17142640 Light chain deposition disease Light chain deposition disease Start 4-Low

Hematology-oncology

 No matching publication found!
1981 Q3680952 myeloid sarcoma Myeloid sarcoma Start 4-Low

Dermatology

Hematology-oncology

 No matching publication found!
2365 Q6865354 Minimally differentiated acute myeloblastic leukemia Minimally differentiated acute myeloblastic leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!
2358 Q6821415 mesoblastic nephroma Mesoblastic nephroma Stub 4-Low

Hematology-oncology

Nephrology

 No matching publication found!
325 Q245455 chromosome 5q deletion syndrome Chromosome 5q deletion syndrome Start 4-Low

Hematology-oncology

Medical genetics

 No matching publication found!
12850 Q1151300 autoimmune lymphoproliferative syndrome Autoimmune lymphoproliferative syndrome Start 4-Low

Hematology-oncology

 No matching publication found!
2470 Q6947913 Myoepithelioma of the head and neck Myoepithelioma of the head and neck Stub 4-Low

Hematology-oncology

Pathology

 No matching publication found!
836 Q1411740 histiocytosis Histiocytosis Start 4-Low

Dermatology

Hematology-oncology

 No matching publication found!
2930 Q7201765 Plasma cell leukemia Plasma cell leukemia C 4-Low

Hematology-oncology

 No matching publication found!
3848 Q25327023 Hemoglobin J Hemoglobin J Stub 4-Low

Hematology-oncology

 No matching publication found!
1259 Q5432934 familial dysalbuminemic hyperthyroxinemia Familial dysalbuminemic hyperthyroxinemia Stub 4-Low

Hematology-oncology

 No matching publication found!
1636 Q5558486 Giant platelet disorder Giant platelet disorder Stub 4-Low

Hematology-oncology

Pathology

 No matching publication found!
2815 Q7316718 reticular dysgenesis Reticular dysgenesis Stub 4-Low

Hematology-oncology

 No matching publication found!
1291 Q11663712 atypical chronic myeloid leukemia Atypical chronic myeloid leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!
3172 Q4674171 Acinic cell carcinoma of the lung Acinic cell carcinoma of the lung Stub 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
3171 Q4674158 Acinar cell carcinoma of the pancreas Acinar cell carcinoma of the pancreas Start 4-Low

Hematology-oncology

Pathology

 No matching publication found!
1292 Q11668606 Myelodysplastic–myeloproliferative diseases Myelodysplastic–myeloproliferative diseases Stub 4-Low

Hematology-oncology

 No matching publication found!
3131 Q7577499 Spindle cell rhabdomyosarcoma Spindle cell rhabdomyosarcoma Stub 4-Low

Hematology-oncology

 No matching publication found!
1307 Q611571 hemorrhagic disease Bleeding diathesis Start 4-Low

Hematology-oncology
  1. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. PMID: 11034761 [NOT CITED] [LATEST Version]
1578 Q1518637 VIPoma VIPoma Start 4-Low

Hematology-oncology

 No matching publication found!
1566 Q1506216 Hermansky-Pudlak syndrome Hermansky–Pudlak syndrome Start 4-Low

Dermatology

Hematology-oncology

 No matching publication found!
3076 Q4811532 astroblastoma Astroblastoma C 4-Low

Hematology-oncology
  1. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. PMID: 26118544 [NOT CITED] [LATEST Version]
1377 Q5383691 Epithelial-myoepithelial carcinoma Epithelial-myoepithelial carcinoma Stub 4-Low

Hematology-oncology

Pathology

 No matching publication found!
1451 Q541244 hereditary spherocytosis Hereditary spherocytosis C 4-Low

Hematology-oncology

 No matching publication found!
3031 Q7159224 Pediatric ependymoma Pediatric ependymoma C 4-Low

Hematology-oncology

 No matching publication found!
2897 Q4677921 Acute eosinophilic leukemia Acute eosinophilic leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!
1537 Q1504570 protein C deficiency Protein C deficiency Start 4-Low

Hematology-oncology

 No matching publication found!
2808 Q7312494 Renal medullary carcinoma Renal medullary carcinoma C 4-Low

Hematology-oncology

Nephrology

 No matching publication found!
3864 Q890200 blood coagulation disease Coagulopathy Start 4-Low

Hematology-oncology
  1. Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm. PMID: 29897100 [NOT CITED] [LATEST Version]
  2. Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm. PMID: 27176127 [NOT CITED] [OLD Version]
  3. Damage control surgery for abdominal trauma. PMID: 23543551 [NOT CITED] [LATEST Version]
  4. Damage control surgery for abdominal trauma. PMID: 20091634 [NOT CITED] [OLD Version]
  5. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. PMID: 17054222 [NOT CITED] [LATEST Version]
  6. Fresh frozen plasma for cardiovascular surgery. PMID: 26171897 [NOT CITED] [LATEST Version]
  7. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. PMID: 26017019 [NOT CITED] [LATEST Version]
  8. Methods for blood loss estimation after vaginal birth. PMID: 30211952 [NOT CITED] [LATEST Version]
  9. Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation. PMID: 28945930 [NOT CITED] [LATEST Version]
  10. Prophylactic plasma transfusion for patients undergoing non-cardiac surgery. PMID: 29151811 [NOT CITED] [LATEST Version]
  11. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. PMID: 26151108 [NOT CITED] [LATEST Version]
  12. Snake antivenom for snake venom induced consumption coagulopathy. PMID: 26058967 [NOT CITED] [LATEST Version]
  13. Surfactant for pulmonary haemorrhage in neonates. PMID: 22786495 [NOT CITED] [LATEST Version]
  14. Surfactant for pulmonary hemorrhage in neonates. PMID: 18425914 [NOT CITED] [LATEST Version]
  15. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. PMID: 21412912 [NOT CITED] [LATEST Version]
  16. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. PMID: 25686465 [NOT CITED] [LATEST Version]
  17. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. PMID: 27552162 [NOT CITED] [LATEST Version]
2802 Q7269853 Quebec platelet disorder Quebec platelet disorder Start 4-Low

Hematology-oncology

 No matching publication found!
1159 Q5275415 Diffuse infiltrative lymphocytosis syndrome Diffuse infiltrative lymphocytosis syndrome Stub 4-Low

Hematology-oncology

Neurology

 No matching publication found!
868 Q5113976 Chronic eosinophilic leukemia Chronic eosinophilic leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!
918 Q1422034 Cronkhite-Canada syndrome Cronkhite–Canada syndrome Start 4-Low

Dermatology

Hematology-oncology

Pathology

 No matching publication found!
1767 Q3801629 Hypoprothrombinemia Hypoprothrombinemia C 4-Low

Hematology-oncology

 No matching publication found!
1759 Q1594599 Post-transplant lymphoproliferative disorder Post-transplant lymphoproliferative disorder Start 4-Low

Hematology-oncology
  1. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. PMID: 28073178 [NOT CITED] [LATEST Version]
965 Q5160407 congenital afibrinogenemia Congenital afibrinogenemia Start 4-Low

Hematology-oncology

 No matching publication found!
966 Q5160405 congenital amegakaryocytic thrombocytopenia Congenital amegakaryocytic thrombocytopenia Start 4-Low

Hematology-oncology

 No matching publication found!
3675 Q861845 kernicterus Kernicterus Start 4-Low

Hematology-oncology

Neurology
  1. Fluid supplementation for neonatal unconjugated hyperbilirubinaemia. PMID: 28762235 [NOT CITED] [LATEST Version]
  2. Immunoglobulin for alloimmune hemolytic disease in neonates. PMID: 29551014 [NOT CITED] [LATEST Version]
  3. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. PMID: 12804504 [NOT CITED] [LATEST Version]
  4. Single versus double volume exchange transfusion in jaundiced newborn infants. PMID: 17054210 [NOT CITED] [LATEST Version]
3641 Q7834208 transfusion hemosiderosis Transfusion hemosiderosis Stub 4-Low

Hematology-oncology

 No matching publication found!
2727 Q7098798 Optic nerve tumor Optic nerve tumor Start 4-Low

Hematology-oncology

Ophthalmology

 No matching publication found!
3515 Q4866195 Basaloid large cell carcinoma of the lung Basaloid large cell carcinoma of the lung Start 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
3491 Q1914356 May–Hegglin anomaly May–Hegglin anomaly Start 4-Low

Hematology-oncology

 No matching publication found!
1721 Q5598273 Gray platelet syndrome Gray platelet syndrome Stub 4-Low

Hematology-oncology

 No matching publication found!
3458 Q7437571 Scott syndrome Scott syndrome Stub 4-Low

Hematology-oncology

 No matching publication found!
3431 Q4751018 Analbuminaemia Analbuminaemia Stub 4-Low

Hematology-oncology

 No matching publication found!
1671 Q1529258 Glanzmann's thrombasthenia Glanzmann's thrombasthenia Start 4-Low

Hematology-oncology

Medical genetics

 No matching publication found!
3398 Q825923 signet ring cell adenocarcinoma Signet ring cell carcinoma Start 4-Low

Hematology-oncology

 No matching publication found!
3393 Q822228 Bernard-Soulier syndrome Bernard–Soulier syndrome C 4-Low

Hematology-oncology

 No matching publication found!
1213 Q1479494 paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria B 4-Low

Dermatology

Hematology-oncology
  1. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. PMID: 25356860 [CITED] [LATEST Version]
870 Q5113990 Chronic phase chronic myelogenous leukemia Chronic phase chronic myelogenous leukemia Stub 4-Low

Hematology-oncology

 No matching publication found!